P (2010-2018)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2018

+Studies in 2000-2009 List
*Studies in Pre-2000 List
>Information in Another Section

PAIN*+
PANCREAS/PANCREATITIS +
>PANHYPOPITUITARISM (See News Articles 2010-2018)
PARKINSON’S DISEASE*+
PATENTS RELATED TO CANNABIS*+
PERINATAL ASPHYXIA (Brain Damage Due To A Lack Of Oxygen During Birth)
PERINATAL HYPOXIC-ISCHEMIC INJURY (Stroke in Infants, See Also STROKES)
PERIPHERAL NERVOUS SYSTEM (All of Your Nervous System That isn’t Your Spine or Brain)

PHANTOM LIMB SYNDROME + (See News Articles 2010-2018, See Also NEUROPATHIC PAIN)
PHARC/POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA and CATARACT SYNDROME
PHOTOBIOMODULATION/LOW LEVEL LASAR THERAPY (LLLT) (Light Therapy Using  Lasers or LEDs to Improve Tissue Repair, Reduce Pain, etc)
PLACEBO EFFECT
+

POISONING-HEAVY METAL*+
POISONING-ORGANOPHOSPHATE +
POISONING-OTHER
POISONING-PARAQUAT*+
POISONING–ROTENONE
POLLS and SURVEYS
>PORPHYRIA (See News Articles 2010-2018)
POST-OPERATIVE COGNITIVE DYSFUNCTION/POCD/“BRAIN FOG”
POST OPERATIVE ILEUS(Slow-down of the Digestive System After a Bowel Operation)
POST-OPERATIVE PAIN +
POLLUTION/ENVIRONMENT (See Also DRUG TESTING–WASTEWATER)
POST POLIO SYNDROME +
POST-TRAUMATIC STRESS DISORDER/FEAR EXTINCTION/FEAR MEMORY +
POTENCY
PRADER WILLI SYNDROME
PREGNANCY/PRENATAL EXPOSURE*+ (See Also PERINATAL HYPOXIC-ISCHEMIC INJURY, CHILDREN/YOUNG ADULTS)
PRIMARY LATERAL SCLEROSIS (A Disease Causing Muscle Nerve Cells to Slowly Break Down, Causing Weakness)

PRIONS +
>PROMM/PROXIMAL MYOTONIC MYOPATHY (See 2000-2009 List)
PROSTATIC HYPERPLASIA/BPH/ENLARGED PROSTATE GLAND/PROSTATITIS
PRURITIS/ITCH + (Chronic Itch)
PSEUDOMONAS AERUGINOSA
PSORIASIS +
PYODERMA GANGRENOSUM (Skin Disease Where a Painful Pustule Breaks Down to Form an Ulcer. There is no Gangrene Infection Involved, the Name Relates to the Appearance of the Blue-Black Edge [‘gangrenosum’])

top


PAIN*+
Evidence for a Role of Endocannabinoids, Astrocytes and p38 Phosphorylation in the Resolution of Postoperative Pain (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878341/?tool=pmcentrez
Endocannabinoid involvement in endometriosis (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972363/
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871326/
Pain related behaviors and neurochemical alterations in mice expressing sickle  hemoglobin: modulation by cannabinoids (full-2010)  http://bloodjournal.hematologylibrary.org/content/116/3/456.long
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the  efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with  intractable cancer-related pain (full-2010) http://www.jpsmjournal.com/article/S0885-3924(09)00787-8/fulltext
Historical essay: An Arabic surgeon, Ibn al Quff’s (1232-1286) account on surgical pain  relief (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173333/
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260554/
NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System (full–2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033984/
Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain (full–2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826109/
Investigational pharmacology for low back pain (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004649/?tool=pmcentrez
Spinal and peripheral analgesic effects of the CB cannabinoid receptor agonist AM1241  in two models of bone cancer-induced pain (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931557/?tool=pubmed
Standardized Cannabis in Multiple Sclerosis: A Case Report (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806860/?tool=pubmed
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant  for administration by ingestion or other means (Health Canada) (full–2010)  http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
New Era Dawns on Sickle Cell Pain (full-2010)  http://bloodjournal.hematologylibrary.org/cgi/reprint/116/3/311
CB2: a cannabinoid receptor with an identity crisis (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931549/?tool=pubmed
The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931567/?tool=pubmed
The Role of Cannabinoid Receptors in the Descending Modulation of Pain (link to PDF-2010) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.634.4866&rank=72
Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic neuralgia (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/19744255
Dronabinol for the treatment of unspecific pain, restlessness and spasticity in neuropaediatrics (abst–2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0030-1265622
Role of cannabinoids in the treatment of pain and (painful) spasticity (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21142261
Electroacupuncture increases CB2 receptor expression on keratinocytes and infiltrating inflammatory cells in inflamed skin tissues of rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20627823
Cannabinoid receptor CB1-immunoreactive nerve fibres in painful and non-painful human tooth pulp (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20705472
Multiple sclerosis-related central pain disorders (abst–2010)  https://www.ncbi.nlm.nih.gov/pubmed/20425191
Pharmacological Management of Pain in Patients with Multiple Sclerosis (abst–2010) https://link.springer.com/article/10.2165%2F11537930-000000000-00000
Analgesic effect of Corydalis yanhusuo in a rat model of trigeminal neuropathic pain  (abst–2010) https://www.ncbi.nlm.nih.gov/pubmed/20855279
Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20176435
Cannabinoids modulate hippocampal memory and plasticity (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/19830813
A catalytically silent FAAH-1 variant drives anandamide transport in neurons (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245783/
top
Brief Report: Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249239/
Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034677/?tool=pubmed
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281798/
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief (full–2011) http://www.hindawi.com/isrn/anesthesiology/2011/593894/
Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041249/
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104059/
Sex Differences in Cannabinoid 1 vs. Cannabinoid 2 Receptor-Selective Antagonism of Antinociception Produced by Δ9-Tetrahydrocannabinol and CP55,940 in the Rat (full–2011) http://jpet.aspetjournals.org/content/340/3/787.full
Pharmacological characterization of AM1710, a putative cannabinoid CB(2) agonist from the cannabilactone class: Antinociception without central nervous system side-effects (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089437/pdf/nihms280008.pdf
Cannabinoids for Treatment of Chronic Non-Cancer Pain; a Systematic Review of
Randomized Trials (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243008/
Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164582/
Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779783/
High levels of N-palmitoylethanolamide and N-stearoylethanolamide in microdialysate samples from myalgic trapezius muscle in women (full–2011) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0027257
Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388539/
Cannabinoids attenuate cancer pain and proliferation in a mouse model (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099480/
US Patent 7884133 B2 Cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentyl-phenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as analgesics, anti-inflammatory and antidiarrheal agents (full–2011) https://www.google.com/patents/US7884133?dq=patent+7884133&hl=en&sa=X&ei=Ujb0U_6EEIW5ogSl84LYDg&ved=0CB4Q6AEwAA
TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ9-tetrahydrocannabiorcol (full–2011) http://www.nature.com/ncomms/journal/v2/n11/full/ncomms1559.html
The intersection between cannabis and cancer in the United States (full–2011) http://www.croh-online.com/article/S1040-8428(11)00231-9/fulltext
Intrathecal Administration of the Cannabinoid 2 Receptor Agonist JWH015 Can Attenuate Cancer Pain and Decrease mRNA Expression of the 2B Subunit of N-Methyld-AsparticAcid (full–2011) http://journals.lww.com/anesthesia-analgesia/Fulltext/2011/08000/Intrathecal_Administration_of_the_Cannabinoid_2.33.aspx
Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health Related Quality of Life (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080871/?tool=pubmed
An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in  California (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673028/
The Antinociceptive Effects of JWH-015 in Chronic Inflammatory Pain Are Produced by  Nitric Oxide-cGMP-PKG-KATP Pathway Activation Mediated by Opioids (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198780/?tool=pubmed
Role of Cannabinoids in Multiple Sclerosis (link to PDF-2011) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.659.8269&rank=26
Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity (link to download-2011)  https://www.academia.edu/819089/Cannabis_in_Palliative_Medicine_Improving_Care_and_Reducing_Opioid-Related_Morbidity?auto=download
The Use of Marijuana or Synthetic Cannabinoids for the Treatment of Headache (1st page–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2011.01848.x/abstract
Treating pain in multiple sclerosis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21916786
top
Effects of repeated electroacupuncture on gene expression of cannabinoid receptor-1 and dopamine 1 receptor in nucleus accumbens-caudate nucleus region in inflammatory-pain rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21585053
A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’ (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22646020
Cannabinoid-opioid interaction in chronic pain (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/22048225/abstract/Cannabinoid_opioid_interaction_in_chronic_pain_
Antinociception and sedation following intracerebroventricular administration of Δ⁹-tetrahydrocannabinol in female vs. male rats (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/20692296/abstract/Antinociception_and_sedation_following_intracerebroventricular_administration_of_%CE%94%E2%81%B9_tetrahydrocannabinol_in_female_vs__male_rats_
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
The antinociceptive potency of N-arachidonoyl-dopamine (NADA) and its interaction with endomorphin-1 at the spinal level (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21624393
A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21864979
FROM GHENNAB TO CANNABIS: HOPES TO FIND A CURE FOR MULTIPLE SCLEROSIS ARE FLOURISHING (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=228000
Cannabinoid mediated diuresis in mice (abst–2011)  http://www.fasebj.org/content/25/1_Supplement/617.6.abstract?sid=bfb1e75f-05db-4b4a-b24d-cabbb51eb934

Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2  receptors in chronically inflamed mice (abst-2011)  https://www.ncbi.nlm.nih.gov/pubmed/21771590
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed  skin tissues through activation of cannabinoid CB2 receptors (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/22337285
Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat  bone tumor pain model (abst–2011)  http://www.sciencedirect.com/science/article/pii/S0304394010016228?via%3Dihub
New targets, new drugs for metastatic bone pain: a new philosophy (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21623686
Early exposure to Environmental enrichment alters the expression of genes of the  endocannabinoid system (abst–2011)  http://www.unboundmedicine.com/medline/ebm/record/21419109/abstract/Early_exposure_to_Environmental_enrichment_alters_the_expression_of_genes_of_the_endocannabinoid_system_
Role of GLT-1 transporter activation in prevention of cannabinoid tolerance by the β-
lactam antibiotic, ceftriaxone, in mice (abst–2011)  http://www.sciencedirect.com/science/article/pii/S0091305711001225
THC-methadone and THC-naltrexone interactions on discrimination, antinociception,  and locomotion in rats (abst-2011)  http://www.unboundmedicine.com/medline/ebm/record/21716095/abstract/THC_methadone_and_THC_naltrexone_interactions_on_discrimination_antinociception_and_locomotion_in_rats_
Medical cannabis use in post-traumatic stress disorder: a naturalistic observational study (abst–2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=481
Spinal Cord Injuries Induce Changes of CB1 Cannabinoid Receptor and C-C Chemokine  Expression in Brain Areas Underlying Circuitry of Chronic Pain Conditions (abst–2011) https://www.ncbi.nlm.nih.gov/pubmed/21265596
Activation of cannabinoid receptors by the pentacyclic triterpene α,β-amyrin inhibits  inflammatory and neuropathic persistent pain in mice (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21620566
Medical Marijuana: Clearing Away the Smoke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358713/
The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959123/
Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02179.x/full
Differences in peripheral endocannabinoid modulation of scratching behavior in facial vs spinally-innervated skin (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394407/
“Redundancy” of endocannabinoid inactivation: new challenges and opportunities for pain control (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382450/
Therapeutic modulation of cannabinoid lipid signaling: Metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493696/
top
The effects of peptide and lipid endocannabinoids on arthritic pain at the spinal level (full–2012) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2012/06000/The_Effects_of_Peptide_and_Lipid_Endocannabinoids.30.aspx
Synergistic interaction of pregabalin with the synthetic cannabinoid WIN 55,212-2 mesylate in the hot-plate test in mice: an isobolographic analysis (full–2012) http://www.if-pan.krakow.pl/pjp/pdf/2012/3_723.pdf
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Non-inflammatory Pain (full–2012) http://jpet.aspetjournals.org/content/338/1/114.full
Cannabidiol in humans-the quest for therapeutic targets (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/24281562
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423256/
The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical hyper-algesia in patients with neuromyelitis optica (full–2012) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0071500
Neonatal DSP-4 Treatment Modifies Antinociceptive Effects of the CB(1) Receptor Agonist Methanandamide in Adult Rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526738/
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Effects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578305/
Activation of Type 5 Metabotropic Glutamate Receptors and Diacylglycerol Lipase-α Initiates 2-Arachidonoylglycerol Formation and Endocannabinoid-Mediated Analgesia (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652685/
Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366638/
The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy (full–2012) http://www.molecularpain.com/content/8/1/71
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500919/
Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters – A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0050968
top
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3312.long
Endocannabinoids in nervous system health and disease: the big picture in a nutshell  (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full

Dynamic changes to the endocannabinoid system in models of chronic pain (full–2012)  http://rstb.royalsocietypublishing.org/content/367/1607/3300.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and
restores basal cytokine levels (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603341/
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371734/
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Clinical implications for cannabinoid use in the rheumatic diseases: potential for help or  harm? (full-2012) http://onlinelibrary.wiley.com/doi/10.1002/art.34522/full
The role of cannabinoids in prostate cancer: Basic science perspective and potential  clinical applications (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339795/?tool=pubmed
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2  receptor agonists (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/jbmr.1732/full
Multiple Sclerosis and Extract of Cannabis: results of the MUSEC trial (full–2012)  http://jnnp.bmj.com/content/83/11/1125.long
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled  trial (full–2012) http://www.cmaj.ca/content/184/10/1143.long
Palmitoylethanolamide in the Treatment of Chronic Pain Caused by Different  Etiopathogenesis (full–2012)  https://academic.oup.com/painmedicine/article/13/9/1121/1864240
Off-Target Cannabinoid Effects Mediated by GPR55 (full–2012)  https://www.karger.com/Article/FullText/336872

The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical  hyperalgesia in patients with neuromyelitis optica (full–2012)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0071500
Topical Compositions with Cannabis Extracts United States Patent Application  20120264818 (full–2012) http://www.freepatentsonline.com/y2012/0264818.html
Monoacylglycerol lipase – a target for drug development? (download–2012)  http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01950.x/pdf
Neuromodulators for pain management in rheumatoid arthritis (abst/summary–2012)  http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008921.pub2/abstract
Cannabinoids and muscular pain. Effectiveness of the local administration in rat (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22354705
Behavioral effects of pulp exposure in mice lacking cannabinoid receptor 2 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22152627
Cannabinergic Pain Medicine: A Concise Clinical Primer and Survey of Randomized controlled Trial Results (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22367503
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features and Emerging Specificities of the Two Major Endocannabinoids (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22801993
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22420307
Role of cannabinoid 2 receptor in the development of bone cancer pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22490961
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial (abst-2012) http://www.sciencedirect.com/science/article/pii/S1526590012000193
Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22337336
The interaction between intrathecal administration of low doses of palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-β expression in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22201038
Acute Reduction of Anandamide-Hydrolase (FAAH) Activity is Coupled With a Reduction of Nociceptive Pathways Facilitation in Medication-Overuse Headache Subjects After Withdrawal Treatment (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2012.02170.x/abstract
Analgesic effects of cannabinoids on central pain syndrome (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22359935
Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22880540
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22954177
Effects of dronabinol on morphine-induced dopamine-related behavioral effects in animals (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/syn.21586/abstract
Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23138934
Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22558609
Olvanil acts on transient receptor potential vanilloid channel 1 and cannabinoid receptors to modulate neuronal transmission in the trigeminovascular system (abst–2012) http://journals.lww.com/pain/Abstract/2012/11000/Olvanil_acts_on_transient_receptor_potential.13.aspx
Endocannabinoid modulation of jejunal afferent responses to LPS (abst–2012)  https://www.ncbi.nlm.nih.gov/pubmed/22734449
A questionnaire survey of patients and carers of patients prescribed Sativex as an  unlicensed medicine (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22784399
Contribution of genetic variants to pain susceptibility in Parkinson disease (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22473870
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in
anti-nociceptive responses after experimental spinal cord injury (full–2013) http://www.sciencedirect.com/science/article/pii/S0306452213007835
Differential modulation of nociceptive versus non-nociceptive synapses by endocannabinoids (full–2013) http://www.molecularpain.com/content/pdf/1744-8069-9-26.pdf
Role of endogenous cannabinoid system in the gut (full-2013) http://www.actaps.com.cn/qikan/manage/wenzhang/2013-4-12.pdf
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643547/
The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717616/
top
Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist (full–2013) http://journals.sagepub.com/doi/full/10.1186/1744-8069-9-26
On the g-protein-coupled receptor heteromers and their allosteric receptor-receptor interactions in the central nervous system: focus on their role in pain modulation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730365/
The endocannabinoid system, cannabinoids, and pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Cannabinoid receptors and pain (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/wmts.83/full
Amygdala activity contributes to the dissociative effect of cannabis on pain perception (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549497/
Dissociation of the Pharmacological Effects of THC by mTOR Blockade (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656376/
Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract (full–2013) http://www.jpp.krakow.pl/journal/archive/04_13/pdf/167_04_13_article.pdf
CB1 and CB2 Cannabinoid Receptor Agonists Induce Peripheral Antinociception by Activation of the Endogenous Noradrenergic System (full–2013) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2013/02000/CB1_and_CB2_Cannabinoid_Receptor_Agonists_Induce.31.aspx
top
Repeated Low Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains CB1 Receptor Mediated Antinociceptive and Gastroprotective Effects (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657109/
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of Cfiber nociceptors in a murine model of cancer pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753184/
The role of androgen receptor in transcriptional modulation of cannabinoid receptor type 1 gene in rat trigeminal ganglia (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870904/
CB1 Cannabinoid Receptor Agonist Prevents NGF-Induced Sensitization of TRPV1 in Sensory Neurons (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752375/
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana In Daily Marijuana Smokers (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746706/
The Subjective Psychoactive Effects of Oral Dronabinol Studied in a Randomized, Controlled Crossover Clinical Trial For Pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013220/
Targeting the cannabinoid system for pain relief? (full–2013) http://www.e-aat.com/article/S1875-4597%2813%2900119-7/fulltext
The use of cannabinoids in chronic pain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23893276
Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study (full–2013) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085073
β-Arrestins: Regulatory Role and Therapeutic Potential in Opioid and Cannabinoid Receptor-Mediated Analgesia (full–2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804701/
The role of endocannabinoids in pain modulation (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/fcp.12008/pdf
Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive  Traffic via CB1 and “Triptan” Receptors: Implications in Migraine (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771033/
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a  randomised, placebo-controlled trial (full–2013)  http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(13)70159-5/fulltext
Antinociceptive activity without cannabimimetic side effects (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954480/
The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study  Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care (download–2013) http://cannabisclinicians.org/wp-content/uploads/2013/09/Med-Nec-for-Cannabis-in-Cancer-Israel.pdf
Interactions between mu opioid receptor agonists and cannabinoid receptor agonists CP55940 and WIN55212-2 in rhesus monkeys: evaluation of treatment- and abuse related effects (link to download–2013) http://jpet.aspetjournals.org/content/early/2013/03/27/jpet.113.204099.long
Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide (link to download–2013)  http://www.eurekaselect.com/107974/article
Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses  Associated with Osteoarthritis of the Knee Joint (link to PDF–2013)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080440
Different Classes of CB2 Ligands Potentially Useful in the Treatment of Pain (link to PDF–2013) http://www.eurekaselect.com/108399/article
New Insights in Mast Cell Modulation by Palmitoylethanolamide (link to PDF–2013) http://www.eurekaselect.com/107979/article
The role of endocannabinoids in pain modulation (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23278562
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23518609
Involvement of the opioid and cannabinoid systems in pain control: new insights from knockout studies (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23523475
Endocannabinoids: A unique opportunity to develop multitarget analgesics (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23623250
Adolescent peer-rejection persistently alters pain perception and CB1 receptor expression in female rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23669059
Effects of the cannabinoid 2 receptor-selective agonist GW405833 in assays of acute pain-stimulated and paindepressed behavior in rats (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/886.9?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists (abst–2013) http://pubs.acs.org/doi/abs/10.1021/jm4005626
Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ9-tetrahydrocannabinol in the rat (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23707295
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electro-acupuncture on experimental arthritis of the rat temporomandibular joint (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23181276
Administration of micronized palmitoylethanolamide (PEA)-transpolydatin in the treatment of chronic pelvic pain in women affected by endometriosis: preliminary results (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24051945
Pharmacology of Cannabinoid Receptor Agonists and a Cyclooxygenase-2 Inhibitor in Rat Bone Tumor Pain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24008428
Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23784345
Palmitoylethanolamide and stearoylethanolamide levels in the interstitium of the trapezius muscle of women with chronic widespread pain and chronic neck-shoulder pain correlate with pain intensity and sensitivity (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23707281
Anandamide produced by Ca2+-insensitive enzymes induces excitation in primary sensory neurons (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24114173
Peripheral and Spinal Activation of Cannabinoid Receptors by Joint Mobilization Alleviates Postoperative Pain in Mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24120553
The endocannabinoid system mediates aerobic exercise-induced antinociception in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24148812
The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23415738
Postoperative Analgesia in the Jamaican Cannabis User (abst–2013) http://www.tandfonline.com/doi/full/10.1080/02791072.2013.803644#.U9QCtWN8E24
Vestibulodynia: synergy between palmitoylethanolamide + transpolydatin and transcutaneous electrical nerve stimulation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23343704
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists (abst–2013) http://pubs.acs.org/doi/abs/10.1021/jm4005626
The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and  increases intestinal transit in mice (abst–2013)  http://onlinelibrary.wiley.com/doi/10.1111/nmo.12158/full
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model (abst–2013) http://www.sciencedirect.com/science/article/pii/S0028390813005960
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain  (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23621668
Inflammatory signaling as a therapeutic target for the treatment of breast cancer-induced bone pain (abst–2013)  http://www.fasebj.org/content/27/1_Supplement/887.10.short
Non-psychotropic analgesic drugs from the endocannabinoid system: “magic bullet” or  “multiple-target” strategies? (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23500197
A Systems Pharmacology Perspective on the Clinical Development of Fatty Acid Amide Hydrolase Inhibitors for Pain (full–2014) http://www.nature.com/psp/journal/v3/n1/full/psp201372a.html
top
Inhibition of Fatty Acid binding proteins elevates brain anandamide levels and produces analgesia (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976407/
The consequences of pain in early life: injury-induced plasticity in developing pain pathways (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264936/
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology (full-2014) http://www.neurology.org/content/82/17/1556.long
Therapeutic benefits of cannabis: a patient survey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia (full–2014) http://www.sciencedirect.com/science/article/pii/S0306452213010531
Prolonged monoacylglycerol lipase blockade causes equivalent CB1-receptor mediated adaptations in FAAH wild type and knockout mice (full–2014) http://jpet.aspetjournals.org/content/early/2014/05/21/jpet.114.212753.long
Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979158/
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998744/
R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice (full–2014) http://embomolmed.embopress.org/content/6/11/1398.long
top
Impact of efficacy at the mu opioid receptor on antinociceptive effects of combinations of mu opioid receptor agonists and cannabinoid receptor agonists (full–2014) http://jpet.aspetjournals.org/content/early/2014/09/05/jpet.114.216648.long
Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol / high fat diet induced pancreatitis (full–2014) http://www.molecularpain.com/content/10/1/66
NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors (full–2014) http://www.molecularpain.com/content/pdf/1744-8069-10-77.pdf
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2 (full–2014) http://www.mdpi.com/1422-0067/15/8/13637/htm
Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain (full–2014)
http://www.nature.com/npp/journal/v40/n2/full/npp2014198a.html
Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201700/
CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288820/
Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and paindepressed behavior in rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963812/
TRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240254/
Complementary and alternative medical therapies in multiple sclerosis-the american academy of neurology guidelines: a commentary (full–2014)
http://www.clinicaltherapeutics.com/article/S0149-2918%2814%2900684-5/fulltext
Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress Disorder-Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications: A Retrospective Evaluation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165471/
A lipid gate for the peripheral control of pain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228127/
Endocannabinoid system and pain: an introduction (full–2014)  https://www.cambridge.org/core/journals/proceedings-of-the-nutrition-society/article/endocannabinoid-system-and-pain-an-introduction/4C5678CCAD813D1C978C676155E9E39D/core-reader
Peripheral interactions between cannabinoid and opioid systems contribute to the antinociceptive effect of crotalphine (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12488/full
The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full–2014) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
Acute Resistance Exercise Induces Antinociception by Activation of the Endo-cannabinoid System in Rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139418/
Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161674/
Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/nmo.12272/full
Epigenetic Regulation of Genes that Modulate Chronic Stress-induced Visceral Pain in the Peripheral Nervous System (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274248/
Mechanisms of Exercise-Induced Hypoalgesia (full–2014)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302052/
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206939/
Treatment with a Heme Oxygenase 1 Inducer Enhances the Antinociceptive Effects of µ-Opioid, δ-Opioid, and Cannabinoid 2 Receptors during Inflammatory Pain (full–2014) http://jpet.aspetjournals.org/content/351/1/224.long
Endocannabinoid modulation by FAAH and MAGL within the analgesic circuitry of the periaqueductal grey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294036/
Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626020/
The analgesic effect of dipyrone in peripheral tissue involves two different mechanisms: Neuronal KATP channel opening and CB1 receptor activation (full–2014) http://www.sciencedirect.com/science/article/pii/S0014299914005561
top
Effects of Two Different Specific Neck Exercise Interventions on Palmitoylethanolamide and Stearoylethanolamide Concentrations in the Interstitium of the Trapezius Muscle in Women with Chronic Neck Shoulder Pain (full–2014) http://painmedicine.oxfordjournals.org/content/15/8/1379.long
Attenuation of Cystitis and Pain Sensation in Mice Lacking Fatty Acid Amide Hydrolase. (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355044/
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844071/
The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients via a Written Document (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417655/
The Neurobiology of Cancer Pain (abst–2014) http://nro.sagepub.com/content/early/2014/03/24/1073858414525828.abstract
Cannabinoid Receptor Type 1 Antagonist, AM251, Attenuates Mechanical Allodynia and Thermal Hyperalgesia after Burn Injury (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237656/
Patterns and correlates of cannabis use among individuals with HIV/AIDS in Maritime  Canada (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950986/
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis Extracts to Treat Diseases (link to download-2014) http://www.slideshare.net/TheHempSolution/comprehensive-report-on-the-cannabis-extract-movement
Intraganglionic injection of a nitric oxide donator induces afferent mechanical  sensitization that is attenuated by palmitoylethanolamide (link to download–2014)  https://www.researchgate.net/publication/260149956_Intraganglionic_injection_of_a_nitric_oxide_donator_induces_afferent_mechanical_sensitization_that_is_attenuated_by_palmitoylethanolamide
CB2 cannabinoid receptors as a therapeutic target – What does the future hold? (link to download–2014) http://molpharm.aspetjournals.org/content/early/2014/08/08/mol.114.094649.long
Report on Medical Cannabis Research History- What the Science Says (article–2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say

The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice (abst–2014) http://www.sciencedirect.com/science/article/pii/S0944711313003097
Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain full–2014) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23461/full
Involvement of the endocannabinoid system in osteoarthritis pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494687
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/ptr.5265/full
Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494683
Neurotrophins, endocannabinoids and thermo-transient receptor potential: a threesome in pain signalling (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494676
Anandamide in primary sensory neurons: too much of a good thing? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494681
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical Grade Cannabis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747979
Inhibition of Voltage-Gated Na+ Channels by the Synthetic Cannabinoid Ajulemic Acid (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24755846
Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24813296
Dronabinol and chronic pain: importance of mechanistic considerations (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24819592
Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24906199
Cyclic ovarian hormone modulation of supraspinal Δ9-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24951841
Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25010019
Effects of opioids and cannabinoids during chronic morphine treatment in rhesus monkeys (abst–2014) http://www.fasebj.org/content/28/1_Supplement/658.3.abstract?sid=467bb529-0ecc-4ddc-af27-3f56f520a102
Arsenic decreases antinociceptive activity of paracetamol: Possible involvement of sero-tonergic and endocannabinoid receptors (abst–2014)
top
Fibromyalgia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24365316
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25064178
Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25150831
Cannabidiol and endogenous opioid peptide-mediated mechanisms modulate anti-nociception induced by transcutaneous electrostimulation of the peripheral nervous system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25282545
Colitis generates remote antinociception in rats: the role of the Larginine/NO/cGMP/ PKG/KATP pathway and involvement of cannabinoid and opioid systems (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25286904
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25331416
Interaction of a Cannabinoid-2 Agonist With Tramadol on Nociceptive Thresholds and Immune Responses in a Rat Model of Incisional Pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25370921
Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446925
Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25447594
Involvement of the endocannabinoid system in attentional modulation of nociceptive behaviour in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25504741
Potential applications of marijuana and cannabinoids in medicine (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
Experience of adjunctive cannabis use for chronic non-cancer pain: Findings from the Pain and Opioids IN Treatment (POINT) study (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25533893
Re-branding cannabis: the next generation of chronic pain medicine? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25537695
Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25543004
Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25485642
Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn’s disease (abst–2014) https://www.ncbi.nlm.nih.gov/pubmed/24407485
Toward modulation of the endocannabinoid system for treatment of gastrointestinal  disease: FAAHster but not “higher” (abst–2014)  http://onlinelibrary.wiley.com/doi/10.1111/nmo.12329/full
Physical activity and the endocannabinoid system: an overview (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24526057
Cannabis (Medical Marijuana) Treatment for Motor and Non-Motor Symptoms of  Parkinson Disease: An Open-Label Observational Study (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24614667
Terpenes and Lipids of the Endocannabinoid and Transient Receptor Potential-channel  Biosignaling Systems (abst–2014) http://pubs.acs.org/doi/abs/10.1021/cn5000875

Selective monoacylglycerol lipase inhibitors: Antinociceptive vs. cannabimimetic effects in mice (full–2015) http://jpet.aspetjournals.org/content/353/2/424.full.pdf+html
The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Peri-aqueduactal Grey (full–2015) http://molpharm.aspetjournals.org/content/early/2015/05/12/mol.115.099333.long
Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice (full–2015) http://jpet.aspetjournals.org/content/354/2/111.full
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (full–2015) http://ssw.umich.edu/sites/default/files/documents/news/use-of-prescription-pain-medications-amongmedical-cannabis-patients.pdf
Intrathecal cannabinoid-1 receptor agonist prevents referred hyperalgesia in acute acrolein-induced cystitis in rats (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446380/
Cannabis in cancer care (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.108/full
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284516/
Coadministration of indomethacin and minocycline attenuates established paclitaxel induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors (full–2015) http://www.nature.com/srep/2015/150618/srep10541/pdf/srep10541.pdf
A survey of cannabis (marijuana) use and self-reported benefit in men with chronic prostatitis/chronic pelvic pain syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25553163
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002194
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity (full–2015) http://ijnp.oxfordjournals.org/content/early/2015/09/04/ijnp.pyv095.long
top
The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002286
Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541447/
Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Témiscamingue region of Quebec (full–2015) http://cmajopen.ca/content/3/2/E251.full?sid=139f05c1-b441-476b-99ff-addf8c918e1a
Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251&resultClick=24
Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid / N-acylethanolamine-dependent mechanisms (full–2015) http://molecularpain.biomedcentral.com/articles/10.1186/s12990-015-0056-8
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Systematic Review of the Use of Phytochemicals for Management of Pain in Cancer Therapy (full–2015) http://www.hindawi.com/journals/bmri/2015/506327/
Activation of Cannabinoid CB2 receptors Reduces Hyperalgesia in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis (full-2015) http://onlinelibrary.wiley.com/doi/10.1111/cns.12349/full
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251
Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Témiscamingue region of Quebec (full–2015) http://cmajopen.ca/content/3/2/E251.full?sid=139f05c1-b441-476b-99ff-addf8c918e1a
Orexin-A and Endocannabinoid Activation of the Descending Antinociceptive Pathway
Underlies Altered Pain Perception in Leptin Signalling Deficiency (full–2015) http://www.nature.com/npp/journal/v41/n2/full/npp2015173a.html
Endocannabinoids and acute pain after total knee arthroplasty (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299927/
Cannabinoids in the management of chronic pain: a front line clinical perspective (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0059/jbcpp-2015-0059.xml
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26067584
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience (full–2015) http://www.jpsmjournal.com/article/S0885-3924(14)00312-1/fulltext
Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9-tetrahydrocannabinol in adult rats (full-2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430373/
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review (full–2015) http://jama.jamanetwork.com/article.aspx? articleid=2338266
Sequelae of Cannabis as Medicine (full–2015) http://painmedicine.oxfordjournals.org/content/16/7/1447
Anandamide Depresses Glycinergic and GABAergic Inhibitory Transmissions in Adult Rat Substantia Gelatinosa Neurons (full–2015) http://file.scirp.org/Html/1-2500613_54452.htm
Use of paracetamol during pregnancy and child neurological development (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/dmcn.12745/full
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152762/
Fatty acid amide hydrolase inhibitors: a patent review (2009-2014) (full–2015)  http://www.tandfonline.com/doi/full/10.1517/13543776.2015.1067683
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549715/
Diet-induced changes in n-3 and n-6 derived endocannabinoids and reductions in headache pain and psychological distress (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522350/
The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation: a case report (abst–2015) http://link.springer.com/article/10.1007/s12630-015-0525-6
Molecular Targets of Cannabidiol in Neurological Disorders (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604182/

Efficacy, tolerability and safety of cannabinoid treatments in the rheumatic diseases: A  systematic review of randomized controlled trials (full–2015)  http://onlinelibrary.wiley.com/doi/10.1002/acr.22727/full
Brain Mapping-Based Model of Δ9-Tetrahydrocannabinol Effects on Connectivity in the  Pain Matrix (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832029/
Cannabis in cancer care (full–2015) http://escholarship.org/uc/item/6367m6vj#page-1
A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and  Cyclooxygenase (COX) To Treat Pain and Inflammation (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840092/
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS) (full–2015) http://www.jpain.org/article/S1526-5900(15)00837-8/fulltext
Additive antinociceptive effects of mixtures of the κ-opioid receptor agonist spiradoline  and the cannabinoid receptor agonist CP55940 in rats (full–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26292184
The modulatory effect of anandamide on nitroglycerin-induced sensitization in the  trigeminal system of the rat (download–2015) http://publicatio.bibl.u-szeged.hu/6219/1/Nagy-G.%20G.%20Felt%C3%B6lt%C3%A9skor%20gener%C3%A1lt%281%29.pdf
The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats (link to download–2015)  http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=4378&category_id=119&option=com_virtuemart&vmcchk=1&Itemid=1
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/nmo.12563/full
Cannabinoid receptor-specific mechanisms to ameliorate pain in sickle cell anemia via  inhibition of mast cell activation and neurogenic inflammation (link to PDF–2015) http://www.haematologica.org/content/early/2015/12/21/haematol.2015.136523.long
Acupuncture Mechanisms: Anesthesia, Analgesia and Protection on Organ Functions (link to PDF–2015) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.732.8262&rank=2&q=cannabinoid&osm=&ossid
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats (full–2015) http://www.cps.org.tw/files/201503160252300.pdf
Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates (article–2015) http://journalofethics.ama-assn.org/2015/06/pfor2-1506.html
Medical marijuana: Hints of headway? Despite a conflicted regulatory landscape, support for medical marijuana is growing amid increasing evidence of potential benefits (Part 2 of 2) (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21524/full
The entourage effect: Synergistic actions of plant cannabinoids (letter–2015) http://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids

Medical Marijuana: Is the Cart Before the Horse? (1st page–2015)  http://jama.jamanetwork.com/article.aspx?articleid=2338230
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (full–2015) http://tinyurl.com/ojn89dh
The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuro-pathic Pain: A Systematic Review (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25635955
Acute administration of a cannabinoid CB1 receptor antagonist impairs stress-induced antinociception in fish (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25656689
Peripherally Restricted Cannabinoids for the Treatment of Pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26497478
Profiles of medicinal cannabis patients attending compassion centers in rhode island (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715068
The role of cannabinoids in regulation of nausea and vomiting, and visceral pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715910
Cannabinoid CB1 receptors mediate the effects of dipyrone (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25430877
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-endoccannabinoid receptor in the ventral mesencephalon (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25841876
top
The role of the endocannabinoid system in pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25846617
Emerging concepts of pain therapy based on neuronal mechanisms (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25846611
Repeated forced swim stress differentially affects formalin-evoked nociceptive behaviour and the endocannabinoid system in stress normo-responsive and stress hyper-responsive rat strains (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25988529
Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25996463
Signaling Mechanism of Cannabinoid Receptor-2 Activation-Induced β-Endorphin Release (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26108183
Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26126926
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26202613
Microinjection of orexin-A into the rat locus coeruleus nucleus induces analgesia via cannabinoid type-1 receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26254729
Clinical pharmacology of medical cannabinoids in chronic pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26267945
Neuropeptide VF Enhances Cannabinoid Agonist WIN55,212-2-Induced Antinociception in Mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26273748
A 4-Week Pilot Study With the Cannabinoid Receptor Agonist Dronabinol and Its Effect
on Metabolic Parameters in a Randomized Trial (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26283236
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26325482
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408049
The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26465930
Receptome: Interactions between three pain-related receptors or the “Triumvirate” of cannabinoid, opioid and TRPV1 receptors (abst–2015)  http://www.sciencedirect.com/science/article/pii/S1043661815002583
The long-term functional consequences of acute infectious diarrhea (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26628101
The Role of the Brain’s Endocannabinoid System in Pain and Its Modulation by Stress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638768
Use of Cannabinoids for Spasticity and Pain Management in MS (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26705757
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26720619
Effects of metabolites of the analgesic agent dipyrone (metamizol) on rostral ventromedial medulla cell activity in mice (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0014299914008929
top
Analysis of the anti-allodynic effects of combination of a synthetic cannabinoid and a selective noradrenaline re-uptake inhibitor in nerve injury-induced neuropathic mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26206340
β-caryophyllene-complexed in β-cyclodextrin Produces Antihyperalgesic Activity in Animal Model for Fibromyalgia (abst–2015) http://www.fasebj.org/content/29/1_Supplement/616.4.abstract?sid=edf921ac-0690-4aa6-ac81- 0546314dd384
Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life Italian monocentric study (abst–2015) http://link.springer.com/article/10.1007/s10072-015-2392-x
Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord (abst–2015) http://link.springer.com/article/10.1007/s10753-015-0168-3
Is cannabis use associated with less opioid use among people who inject drugs? (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2900250-1/abstract
Use of medical cannabis to reduce pain and improve quality of life in cancer patients  (abst–2015) http://meetinglibrary.asco.org/content/155674-165
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2 (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=7042&path%5B%5D=20008
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing Remitting Multiple Sclerosis (full–2016) http://link.springer.com/article/10.1007/s13311-016-0420-z/fulltext.html
δ-Ctenitoxin-Pn1a, a Peptide from Phoneutria nigriventer Spider Venom, Shows Antinociceptive Effect Involving Opioid and Cannabinoid Systems, in Rats (full–2016) http://www.mdpi.com/2072-6651/8/4/106/htm
A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase (full–2016) http://mpx.sagepub.com/content/12/1744806916649192.long
Endovanilloids are potential activators of the trigeminovascular nocisensor complex (full–2016) http://thejournalofheadacheandpain.springeropen.com/articles/10.1186/s10194-016-0644-7
Cannabinoid 1 receptor knockout mice display cold allodynia, but enhanced recovery from spared-nerve injury-induced mechanical hypersensitivity (full–2016) http://mpx.sagepub.com/content/12/1744806916649191.long
Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl (full–2016) http://www.sciencedirect.com/science/article/pii/S0014299916303235
Chest pain, troponin rise, and ST-elevation in an adolescent boy following the use of the synthetic cannabis product K2 (full–2016) http://www.annalspc.com/article.asp?issn=0974- 2069;year=2016;volume=9;issue=1;spage=79;epage=81;aulast=Zaleta
Expression of the endocannabinoid receptors in human fascial tissue (full–2016) http://www.ejh.it/index.php/ejh/article/view/2643/2590
Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems-A Novel Treatment Option for Chronic Pain Management (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00257/full
Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00304/full
Cannabinoid Buccal Spray for Chronic Non-Cancer or Neuropathic Pain: A Review of Clinical Effectiveness, Safety, and Guidelines (full–2016) https://www.ncbi.nlm.nih.gov/books/NBK395789/
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00203/full
Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation (full–2016) http://journals.plos.org/plosone/article? id=10.1371/journal.pone.0167965
Paracetamol sharpens reflection and spatial memory: a double-blind randomized controlled study in healthy volunteers (full–2016) https://www.dovepress.com/paracetamol-sharpens-reflection-and-spatial-memory-a-double-blind-randpeer-reviewed-article-DDDT
Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719019/
A spider derived peptide, PnPP-19, induces central antinociception mediated by opioid and cannabinoid systems (full–2016) https://jvat.biomedcentral.com/articles/10.1186/s40409-016-0091-6
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
Comparative antinociceptive effect of arachidonylcyclopropylamide, a cannabinoid 1  receptor agonist & lignocaine, a local anaesthetic agent, following direct intrawound
administration in rats (full–2016) http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2016;volume=144;issue=5;spage=730;epage=740;aulast=Kumar
Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy  (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165161/
Combined treatment with morphine and Δ9-tetrahydrocannibinol (THC) in rhesus  monkeys: antinociceptive tolerance and withdrawal (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851324/
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders (full–2016) http://www.sciencedirect.com/science/article/pii/S0960894X16306874
Robust anti-nociceptive effects of MAG lipase inhibition in a model of osteoarthritis pain (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056226/
The role of the endocannabinoid system in the brain-gut axis (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961581/
Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to  cannabinoids (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082783/
Sex Differences in Cannabinoid-Regulated Biology: A Focus on Energy Homeostasis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783283/
Differences in Chloride Gradients Allow for Three Distinct Types of Synaptic Modulation by Endocannabinoids (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982905/
Endocannabinoid system: Role in depression, reward and pain control (Review) (full–2016) https://www.spandidos-publications.com/10.3892/mmr.2016.5585
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain:  New insights and future perspectives (full–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26817719
The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological  Targets and Novel Treatments (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056566/
Role of cannabinoids in gastrointestinal mucosal defense and inflammation (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333598/
The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887712/
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the  Treatment of Neuropathic Pain from Spinal Cord Injury and Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007175/
Medical cannabis: considerations for the anesthesiologist and pain physician (full in English, abst in French–2016) https://link.springer.com/article/10.1007%2Fs12630-016-0598-x
β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and
analgesic properties (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083753/
Sex-dependent effects of cannabis-induced analgesia (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037015/
Behavioral Characterization of Kappa Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats (link to download–2016) http://jpet.aspetjournals.org/content/early/2016/11/30/jpet.116.235630.long
Tolerance to the diuretic effects of cannabinoids and cross-tolerance to a kappa-opioid
agonist in THC-treated mice (link to PDF–2016)  http://jpet.aspetjournals.org/content/early/2016/05/26/jpet.116.232132.long
Dissecting the signaling pathways involved in the crosstalk between mGlu5 and CB1  receptors (link to PDF–2016)  http://molpharm.aspetjournals.org/content/early/2016/06/23/mol.116.104372.long
Using Medical Cannabis in an Oncology Practice (article–2016)  http://www.cancernetwork.com/oncology-journal/using-medical-cannabis-oncology-practice#sthash.CjT8fR9n.uWvEhfSG.dpuf
Opioids Out, Cannabis In (1st page-2016) http://jamanetwork.com/journals/jama/article-abstract/2576617
Cannabis and Cannabinoids (1st page–2016)  http://jamanetwork.com/journals/jama/article-abstract/2592497
Cannabinoid pharmacology in cancer research: A new hope for cancer patients? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26852955

Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the  Menstrual Cycle in Women With Endometriosis (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/26887427
Effect of cannabinoids on CGRP release in the isolated rat lumbar spinal cord (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26762784
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26767992
top
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neuro-logical and neurochemical responses in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26780169
Quantification of pain in sickle mice using facial expressions and body measurements (abst–2016) http://www.sciencedirect.com/science/article/pii/S1079979615300218
CB1 Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the Nucleus Accumbens (abst–2016) http://link.springer.com/article/10.1007/s12031-016-0716-9
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review (abst in German & English-2016)  https://link.springer.com/article/10.1007%2Fs00482-015-0087-0
Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26808012
Dronabinol increases pain threshold in patients with functional chest pain: a pilot doubleblind placebo-controlled trial (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26822791
β-caryophyllene, a dietary cannabinoid, complexed with β-cyclodextrin produced antihyperalgesic effect involving the inhibition of Fos expression in superficial dorsal horn (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26883973
Development and Pharmacological Characterization of Selective Blockers of 2- Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.5b01812
Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816300545
Cannabinoids: Medical implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26912385
Nabilone for the Management of Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26923810
A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26935064
Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26942594
Sickle Cell Crisis Complicated by Synthetic Cannabinoid Abuse: A Case Report (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26956672
Cannabis in Pain Treatment: Clinical & Research Considerations (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26961090
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain: A Prospective Open-label Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26889611
Rational Basis for the Use of Bergamot Essential Oil in Complementary Medicine to Treat Chronic Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26996621
Medical cannabis associated with decreased opiate medication use in retrospective crosssectional survey of chronic pain patients (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27001005
Mesoporous Silica Particles as a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27028159
Piperidinyl thiazole isoxazolines: A new series of highly potent, slowly reversible FAAH inhibitors with analgesic properties (abst–2016) http://www.sciencedirect.com/science/article/pii/S0960894X16301834
Adolescent social rejection alters pain processing in a CB1 receptor dependent manner (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27157075
Pain, Cannabis Species, and Cannabis Use Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27172585
MEDICAL CANNABIS (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115
Differences in Chloride Gradients Allow for Three Distinct Types of Synaptic Modulation by Endocannabinoids (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27226449
TRPV1-FAAH-COX: The Couples Game in Pain Treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27240888
Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: a systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27267445
Transmission Pathways and Mediators as the Basis for Clinical Pharmacology of Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27322358
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816305667
PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase (abst–2016) http://onlinelibrary.wiley.com/doi/10.1111/bph.13448/abstract
New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27349158
Changes in nociceptin/orphanin FQ levels in rat brain regions after acute and chronic cannabinoid treatment in conjunction with the development of antinociceptive tolerance (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27371029
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis (abst–2016) http://www.msard-journal.com/article/S2211-0348(16)30056-6/abstract
Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27450703
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27475408
Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses (abst–2016) http://onlinelibrary.wiley.com/doi/10.1113/JP272292/abstract
The Effect of Muscarinic Receptor Modulators on the Antinociception Induced by CB2 Receptor Agonist, JWH133 in Mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27504865
Endocannabinoid mechanism for orofacial antinociception induced by electroacupuncture in acupoint St36 in rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S1734114016300913
Peltatoside Isolated from Annona crassiflora Induces Peripheral Antinociception by Activation of the Cannabinoid System (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/27574895
Activation of cannabinoid CB1 receptor contributes to suppression of spinal nociceptive transmission and inhibition of mechanical hypersensitivity by Aβ-fiber stimulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27589093
Pain in Extrapyramidal Neurodegenerative Diseases (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27623111
N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27649266
Gonadal hormone modulation of ∆9-tetrahydrocannabinol-induced antinociception and metabolism in female versus male rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716301599
Nature of the placebo and nocebo effect in relation to functional neurologic disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27719874
Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson’s disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27723182 Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools (abst–2016) http://www.eurekaselect.com/146167/article
Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and Nacylethanolamine acid amidase inhibitors (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00538
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883
Medical Marijuana: Just the Beginning of a Long, Strange Trip? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27660328
Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27832442
Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27834685
Cannabinoid receptor ligand bias: implications in the central nervous system (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27835801
The central cannabinoid receptor type-2 (CB2) and chronic pain (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27842450
State of the evidence: Cannabinoids and cancer pain-A systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27863159
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816305123
A novel inhibitor of endocannabinoid catabolic enzymes sheds light on behind the scene interplay between chronic pain, analgesic tolerance, and heroin dependence (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816305226
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27919478
Pain in amyotrophic lateral sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27964824
Inflammation of peripheral tissues and injury to peripheral nerves induce diferring effects in the expression of the calcium-sensitive anandamide-synthesising enzyme and related molecules in rat primary sensory neurons (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27997038
Plasma endocannabinoid behaviour in total knee and hip arthroplasty (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28078867
Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the  Menstrual Cycle in Women With Endometriosis (abst–2016)  http://journals.sagepub.com/doi/full/10.1177/1933719116630414
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65875/
Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65755/
Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives (full–2017)  http://meetinglibrary.asco.org/record/140727/edbook#fulltext
Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian  cohort of 614 patients (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449133/
Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of  Incision Pain in Rats (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00391/full
Endocannabinoids Have Opposing Effects On Behavioral Responses To Nociceptive And  Non-nociceptive Stimuli (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517658/
Recent advances in understanding and managing cancer pain (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482325/
Understanding Patients’ Process to Use Medical Marijuana: A Southern New Jersey  Community Engagement Project (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513646/
Cannabis as a substitute for prescription drugs – a cross-sectional study (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422566/
The Use of Cannabis for Headache Disorders (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436334/
The Clinical Significance of Endocannabinoids in Endometriosis Pain Management (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436335/
Cannabis and Pain: A Clinical Review (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549367/
Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569620/
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we
go? (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388177/
Early blockade of joint inflammation with a fatty acid amide hydrolase inhibitor  decreases end-stage osteoarthritis pain and peripheral neuropathy in mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445456/
N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via  Nonhematopoietic TRPV1 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544930/
Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242409/

Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and  central mechanisms (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407663/
Cannabis use among patients at a comprehensive cancer center in a state with legalized  medicinal and recreational use (full–2017)  http://onlinelibrary.wiley.com/doi/10.1002/cncr.30879/full
Cannabinoids in Pain Management and Palliative Medicine (full–2017)  https://www.aerzteblatt.de/int/archive/article?id=193441
Blockade of Cannabinoid CB1 Receptors in the Dorsal Periaqueductal Gray Unmasks the  Antinociceptive Effect of Local Injections of Anandamide in Mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632997/
Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of  osteoarthritis (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573042/
N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with  Widespread Physiological and Pharmacological Activities (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627668/
Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation  and Pain (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628559/
Expert Panel on Understanding Cannabis: Medicine, Society, Government (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657088/
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues  for other neuroinflammatory diseases (full–2017)  http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430528/
Cannabis use in persons with traumatic spinal cord injury in Denmark (full-2017) https://www.medicaljournals.se/jrm/content/html/10.2340/16501977-2105
Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat (full–2017)  http://www.sciencedirect.com/science/article/pii/S0014299917307239?via%3Dihub
Use of ketamine for acute suicidal ideation in a patient with chronic pain on prescribed  cannabinoids (full–2017) http://casereports.bmj.com/content/2017/bcr-2017-222059.long
Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are  associated with neurological phenotypes in humans (full–2017)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187926
Modulating the endocannabinoid pathway as treatment for peripheral neuropathic pain: a selected review of preclinical studies (full–2017)  http://apm.amegroups.com/article/view/16320/16484
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference (full–2017)  https://www.nature.com/articles/s41598-017-17796-y
The Placebo Effect in Cardiology: Understanding and Using It (full in English , abst in French–2017) http://www.onlinecjc.ca/article/S0828-282X(17)31036-X/fulltext
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic  disease (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685274/
Associations between medical cannabis and prescription opioid use in chronic pain  patients: A preliminary cohort study (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187795
Benefits and Harms of Cannabis in Chronic Pain or Post-traumatic Stress Disorder: A  Systematic Review (full–2017)  https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0098113/
[EXPRESS] AMP-activated kinase and the endogenous endocannabinoid system might
contribute to antinociceptive effects of prolonged moderate caloric restriction in mice  (download–2017) http://journals.sagepub.com/doi/pdf/10.1177/1744806917703111
A selective review of medical cannabis in cancer pain management (link to download–2017) http://apm.amegroups.com/article/view/16199/16359
Investigation of Diacylglycerol Lipase Alpha Inhibition in the Mouse Lipopolysaccharide
Inflammatory Pain Model. (link to download–2017)
http://jpet.aspetjournals.org/content/early/2017/10/02/jpet.117.243808.long
Is cannabis an effective treatment for joint pain? (link to PDF-2017)  http://www.clinexprheumatol.org/abstract.asp?a=12225
Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and
Meta-Analysis of Randomized Controlled Trials (link to PDF-2017)  http://www.painphysicianjournal.com/linkout?issn=1533-3159&vol=20&page=E755
Clinical Evidence for Utilizing Cannabinoids in the Elderly (link to PDF–2017)  https://www.ima.org.il/imaj/viewarticle.aspx?year=2017&month=02&page=71
Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome  after Human Papillomavirus Vaccination (link to PDF–2017)  https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4042
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications  (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
The cannabinoid CB2 agonist GW405833 suppresses inflammatory and neuropathic pain  through a CB1 mechanism that is independent of CB2 receptors in mice (link to PDF–2017) http://jpet.aspetjournals.org/content/early/2017/06/07/jpet.117.241901.long
Age dependent plasticity in endocannabinoid modulation of pain processing through  postnatal development (link to PDF–2017)  http://journals.lww.com/pain/Abstract/publishahead/Age_dependent_plasticity_in_endocannabinoid.99170.aspx
N-Acyl amino acids (Elmiric Acids): endogenous signaling molecules with therapeutic  potential (link to PDF-2017)  http://molpharm.aspetjournals.org/content/early/2017/11/14/mol.117.110841.long
Medical Cannabis in the Palliation of Malignant Wounds—A Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain (abst–2017) http://www.ncbi.nlm.nih.gov/pubmed/27346885
Fatty Acid Amide Hydrolase Inhibitor Treatment in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome, an Adaptive Double-Blind Randomized Controlled Trial (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28254462
Cannabinoid signaling in health and disease (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28263083
Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral  type 2 cannabinoid receptor (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1043661816313809
Cannabis for Pain and Headaches: Primer (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28281107
The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0376871617300881
Opioid-sparing Effect of Cannabinoids: A Systematic Review and Meta-analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28327548
Presynaptic and extrasynaptic regulation of posterior nucleus of thalamus (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28331010
Chronic Pain Patients’ Perspectives of Medical Cannabis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28328576
Cannabis, Cannabinoids, and Sleep: a Review of the Literature (abst–2017)  http://link.springer.com/article/10.1007%2Fs11920-017-0775-9
Endocannabinoid and Opioid System Interactions in Exercise-Induced Hypoalgesia (abst –2017) https://www.ncbi.nlm.nih.gov/pubmed/28387833
The endocannabinoid system, a novel and key participant in acupuncture’s multiple  beneficial effects (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0149763417301318
TRP channels as novel targets for endogenous ligands: focus on endocannabinoids and  nociceptive signalling (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28440188
Cannabidiol-Δ9-tetrahydrocannabinol interactions on acute pain and locomotor activity  (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30168-0/fulltext
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28372506
Peripheral inflammation alters N-arachidonoylphosphatidylethanolamine (20:4-NAPE)  induced modulation of nociceptive spinal cord synaptic transmission (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28476070
Systematic review: interventions for abdominal pain management in inflammatory bowel disease (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28470846
AMPK contributes to aerobic exercise-induced antinociception downstream of  endocannabinoids (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301983?via%3Dihub
Contribution of Endocannabinoid Gene Expression and Genotype on Low Back Pain  Susceptibility and Chronicity (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28481838
Continuous Intrathecal Infusion of Cannabinoid Receptor Agonists Attenuates Nerve  Ligation-Induced Pain in Rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28492437
Nociceptor plasticity: a closer look (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28488779
Medical cannabis use among patients with chronic pain in an interdisciplinary pain  rehabilitation program: Characterization and treatment outcomes (abst–2017)  http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(16)30261-6/fulltext
Chronic Inflammatory Pain Impairs mGluR5-Mediated Depolarization-Induced  Suppression of Excitation in the Anterior Cingulate Cortex (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28520841
Acetaminophen Metabolite N-Acylphenolamine Induces Analgesia via Transient  Receptor Potential Vanilloid 1 Receptors Expressed on the Primary Afferent Terminals of C-fibers in the Spinal Dorsal Horn (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28542001
Therapeutic potential of Cannabis sativa (abst in English–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28548193 (full in Spanish)  http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000300010&lng=en&nrm=iso&tlng=en
Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local  inhibition of anandamide hydrolysis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28570479
The Cannabis Information Helpline: Assessing Interest in the Medicinal Use of Cannabis  in Australia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28557590
The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice (abst–2017)  http://www.sciencedirect.com/science/article/pii/S001448861730153X
Morin Suppresses Astrocyte Activation and Regulates Cytokine Release in Bone Cancer  Pain Rat Models (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28618070
The cannabinoid system and pain (abst–2017)  http://www.sciencedirect.com/science/article/pii/S002839081730285X
Serum endocannabinoids in assessing pain in patients with chronic pancreatitis and in  those with pancreatic ductal adenocarcinoma (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28631495
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28653665
Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative (abst–2017) http://www.sciencedirect.com/science/article/pii/S0278584617302233?via%3Dihub
Delta-9-tetrahydrocannabinol decreases masticatory muscle sensitization in female rats  through peripheral cannabinoid receptor activation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28722246
Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in  mice (abst–2017) http://www.sciencedirect.com/science/article/pii/S0028390817303465?via%3Dihub
Cannabinoid system of dorsomedial telencephalon modulates behavioral responses to  noxious stimulation in the fish Leporinus macrocephalus (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28754268
Single oral dose of cannabinoid derivate loaded PLGA nanocarriers relieves neuropathic  pain for eleven days (abst–2017) http://www.nanomedjournal.com/article/S1549-9634(17)30140-5/fulltext
Administrations of thalidomide into the rostral ventromedial medulla produce  antinociceptive effects in a rat model of postoperative pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28758232
Effects of Centrally Administered Endocannabinoids and Opioids on Orofacial Pain  Perception in Rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28771697
Electroacupuncture Inhibits NLRP3 Inflammasome Activation through CB2 Receptors in  Inflammatory Pain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28782714
Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1
simultaneously to modulate colonic motility and visceral sensation in the mouse: A
pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT) (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28695708
Perioperative Patient Beliefs Regarding Potential Effectiveness of Marijuana  (Cannabinoids) for Treatment of Pain: A Prospective Population Survey (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28796754
Topical Medical Cannabis (TMC): A new treatment for wound pain-Three cases of  Pyoderma Gangrenosum (abst–2017) http://www.jpsmjournal.com/article/S0885-3924(17)30351-2/fulltext
Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological  Pain Without Producing Tolerance or Dependence (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28823711
The Role of Nuclear Hormone Receptors in Cannabinoid Function (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28826538
Cannabinoids and Pain: Sites and Mechanisms of Action (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28826543
Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer  (abst–2017) https://link.springer.com/article/10.1007%2Fs00210-017-1419-7
Inhibition of monoacylglycerol lipase: Another signalling pathway for potential  therapeutic targets in migraine? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28816506
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating  Inflammatory and Neuropathic Pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28857069
Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in  inflammatory pain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28879802
Antinociceptive effects of JWH015 in female and male rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28914627
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols  Oromucosal Spray as Adjunctive Therapy in Advanced Cancer Patients With Chronic  Uncontrolled Pain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28923526
Comparison of cannabinoids with known analgesics using a novel high throughput  zebrafish larval model of nociception (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0166432817310239?via%3Dihub
Preferences for Medical Marijuana over Prescription Medications Among Persons Living
with Chronic Conditions: Alternative, Complementary, and Tapering Uses (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28945457
Liposomal Delivery of Diacylglycerol Lipase-Beta Inhibitors to Macrophages  Dramatically Enhances Selectivity and Efficacy in Vivo (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00657
An endocannabinoid uptake inhibitor from black pepper exerts pronounced antiinflammatory effects in mice (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.jafc.7b02979
The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces  analgesia in mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28963716
Salvinorin A reduces neuropathic nociception in the insular cortex of the rat (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28975684
Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn’s Disease  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28981653
Cannabis and Cannabinoids for Chronic Pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28983880
Experts’ Perspectives on the Role of Medical Marijuana in Oncology: a semi-structured  interview study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28040884
In vitro and in vivo pharmacological characterization of ASP8477: A novel highly  selective fatty acid amide hydrolase inhibitor (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29017758
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain  management – An overview of systematic reviews (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29034533
System-specific activity in response to Δ9 -tetrahydrocannabinol: A functional magnetic  resonance imaging study in awake male rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29057576
Medical cannabis for the treatment of chronic pain and other disorders: misconceptions  and facts (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29067992
Mechanisms of placebo analgesia: A dual-process model informed by insights from cross-species comparisons (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0301008217300011?via%3Dihub
Increased expression of type 1 cannabinoid (CB1) receptor among patients with rotator  cuff lesions and shoulder stiffness (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29108858
CB1 Receptors Mediated Inhibition of ATP-Induced [Ca2+]i Increase in Cultured Rat  Spinal Dorsal Horn Neurons (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29127599
The Inhibitory Effects of Cobalt Protoporphyrin IX and Cannabinoid 2 Receptor Agonists in Type 2 Diabetic Mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29143802
Current evidence of cannabinoid-based analgesia obtained in preclinical and human  experimental settings (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29160600
Acetaminophen Relieves Inflammatory Pain Through CB1 Cannabinoid Receptors in the  Rostral Ventromedial Medulla (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29167401
Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid  receptor agonists in rats: impact of drug and fixed-dose ratio (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29183835
The antinociceptive agent SBFI-26 binds to anandamide transporters FABP5 and FABP7  at two different sites (abst–2017) http://pubs.acs.org/doi/10.1021/acs.biochem.7b00194
Differential neuromodulatory role of endocannabinoids in the rodent trigeminal sensory ganglion and cerebral cortex relevant to pain processing (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0028390817306020?via%3Dihub
Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in  dementia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29256923
Preserving the independence of people living with multiple sclerosis towards the end of  life (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29087751
Smartphone-based ecological momentary assessment (EMA) of alcohol and cannabis use  in older adults with and without HIV infection (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0306460317303878?via%3Dihub
The effect of medical marijuana laws on the health and labor supply of older adults:  Evidence from the Health and Retirement Study (abst–2017)  http://www.nber.org/papers/w22688
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep  (abst–2017) http://journals.sagepub.com/doi/abs/10.1177/0269881117699616
Mechanisms and treatment of painful neuromas (full–2018)  https://www.degruyter.com/view/j/revneuro.ahead-of-print/revneuro-2017-0077/revneuro-2017-0077.xml
Molecular Understanding of the Activation of CB1 and Blockade of TRPV1 Receptors:  Implications for Novel Treatment Strategies in Osteoarthritis (full–2018)  http://www.mdpi.com/1422-0067/19/2/342/htm
CB1 cannabinoid receptor agonist mouse VD-hemopressin(α) produced supraspinal  analgesic activity in the preclinical models of pain (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0006899317305474?via%3Dihub
The therapeutic effects of Cannabis and cannabinoids: An update from the National  Academies of Sciences, Engineering and Medicine report (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29325791
The role of cannabinoids in pain control: the good, the bad, and the ugly (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29338150
Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29338578


PANCREAS/PANCREATITIS +
Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse  MIN6 β-cells (full–2010) http://www.karger.com/Article/Pdf/320527
Expression and function of cannabinoid receptors in mouse islets (full–2010) http/www.landesbioscience.com/journals/islets/LiISLETS2-5.pdf
G1359A polymorphism of the cannabinoid receptor gene (CNR1) and clinical results of  biliopancreatic diversion (link to PDF–2010) http://www.europeanreview.org/article/724
Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis (full–2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2010.01569.x/full
The role of small molecule GPR119 agonist, AS1535907, in glucose-stimulated insulin secretion and pancreatic β-cell function (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/21114601
Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells (full–2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064093/
Gut feelings about the endocannabinoid system (full–2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01689.x/full
top
The role of the endocannabinoid system in islet biology (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21311323
The CB-1 Receptor Antagonist Rimonabant Modulates the Interaction Between Adipocytes and Pancreatic Beta-Cells in Vitro (abst–2011) https/www.thieme-connect.com/ejournals/abstract/10.1055/s-0030-1261963
Cannabinoid HU210 Protects Isolated Rat Stomach against Impairment Caused by Serum of Rats with Experimental Acute Pancreatitis (full–2012) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0052921
Activation of Cannabinoid Receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms (full–2012) http/ajpgi.physiology.org/content/304/2/G181
Expression and function of monoacylglycerol lipase in mouse β-cells and human islets of Langerhans (full–2012) http://www.karger.com/Article/Pdf/339069
Islet protection and amelioration of diabetes type 2 in Psammomys obesus by treatment with cannabidiol (full-2012) http://file.scirp.org/Html/17302.html
GPR119 as a fat sensor (full–2012) http://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147%2812%2900054-5
Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484111/
Cannabinoid HU210 Protects Isolated Rat Stomach against Impairment Caused by Serum  of Rats with Experimental Acute Pancreatitis (full-2012)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0052921
Effects of CP 55,940–agonist of CB1 cannabinoid receptors on ghrelin and somatostatin producing cells in the rat pancreas (link to PDF–2012)  https://journals.viamedica.pl/folia_histochemica_cytobiologica/article/view/18705
Cannabis exposure associated with weight reduction and β-cell protection in an obese rat model (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22421529
Honokiol attenuates the severity of acute pancreatitis and associated lung injury via acceleration of acinar cell apoptosis (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22258232
Islet cannabinoid receptors: cellular distribution and biological function (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24005231
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/22850623
Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol / high fat diet induced pancreatitis (full–2014) http://www.molecularpain.com/content/10/1/66
A novel GPR40 agonist, CNX-011-67, suppresses glucagon secretion in pancreatic islets under chronic glucolipotoxic conditions in vitro (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161845/
top
Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083038/
A Role for Trans-caryophyllene in the Moderation of Insulin Secretion (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24486541
Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Δ9 -THC (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25187240
Role of the endocannabinoid system in obesity induced by neuropeptide Y overexpression in noradrenergic neurons (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423197/
Cannabinoid CB1 receptors and mTORC1 signalling pathway interact to modulate glucose homeostasis (full–2015) http://dmm.biologists.org/content/9/1/51.long
Role of the Endocannabinoid System in Diabetes and Diabetic Complications (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13226/full
Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653226/
Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans (full–2015) http://jn.nutrition.org/content/145/9/2169.long
Cannabinoids Regulate Bcl-2 and Cyclin D2 Expression in Pancreatic β Cells (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0150981 Endocannabinoid regulation of β-cell functions: Implications for glycemic control and diabetes (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045244/
Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced Ca(2+) oscillations in mouse pancreatic acinar cells (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949433/
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid  Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo Controlled, Parallel Group Pilot Study (full–2016)  http://care.diabetesjournals.org/content/39/10/1777.long
β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S000927971530154X
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review (abst in German & English-2016)  https://link.springer.com/article/10.1007%2Fs00482-015-0087-0
GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27561953
Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27767974
Immunohistochemistry Detected and Localized Cannabinoid Receptor Type 2 in Bovine  Fetal Pancreas at Late Gestation (full–2017)  http://www.ejh.it/index.php/ejh/article/view/2761/2667
Endocannabinoid system acts as a regulator of immune homeostasis in the gut (full–2017) http://www.pnas.org/content/early/2017/04/18/1612177114.long
Severity and outcomes of acute alcoholic pancreatitis in cannabis users (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539398/
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type-2 Diabetes (abst–2017) http://diabetes.diabetesjournals.org/content/early/2017/01/11/db16-1199.long
Role of cannabis in digestive disorders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/27792038
Serum endocannabinoids in assessing pain in patients with chronic pancreatitis and in  those with pancreatic ductal adenocarcinoma (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28631495
A TRPV1‐to‐secretagogin regulatory axis controls pancreatic β‐cell survival by  modulating protein turnover (abst–2017)  http://emboj.embopress.org/content/early/2017/06/19/embj.201695347.long
Cannabis-Induced Acute Pancreatitis: A Systematic Review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28796137
LH-21 and Abn-CBD improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29205751


PARKINSON’S DISEASE*+
Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders (full–2010) http:// onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00144.x/full
Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848893/?tool=pubmed
Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson’s disease in the rat (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659808/
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data (full–2010) http://www.mdpi.com/1424-8247/3/8/2689/htm
The endocannabinoid system as a target for the treatment of neurodegenerative disease  (full-2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931550/
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant  for administration by ingestion or other means (Health Canada) (full–2010)  http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
The development of cannabinoid CBII receptor agonists for the treatment of central  neuropathies. (link to download–2010) http://www.eurekaselect.com/85808/article
The effects of cannabinoid drugs on abnormal involuntary movements in dyskinetic and non-dyskinetic 6-hydroxydopamine lesioned rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20888328
In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson’s disease (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20026090
top
Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145842/?tool=pubmed
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Prospects for cannabinoid therapies in basal ganglia disorders (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165947/
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation (full–2011)  http://www.jimmunol.org/content/187/12/6508.full?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for  membrane fluidity disturbance (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165948/
Endocannabinoid hydrolysis generates brain prostaglandins that promote  neuroinflammation (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249428/
Symptom-relieving and neuroprotective effects of the phytocannabinoid D(9) -THCV in animal models of Parkinson’s disease (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165958/pdf/bph0163-1495.pdf
Therapeutic Potential of Cannabinoids in the Treatment of Neuroinflammation Associated with Parkinson’s Disease (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21568925/abstract/Therapeutic_Potential_of_Cannabinoids_in_the_Treatment_of_Neuroinflammation_Associated_with_Parkinson%27s_Disease_
Regional changes in type 1 cannabinoid receptor availability in Parkinson’s disease in vivo (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21459482/abstract/Regional_changes_in_type_1_cannabinoid_receptor_availability_in_Parkinson%27s_disease_in_vivo_
Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20862500
Homeostatic changes of the endocannabinoid system in Parkinson’s disease (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21412829/abstract/Homeostatic_changes_of_the_endocannabinoid_system_in_Parkinson%27s_disease_
Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors (abst–2011) http://europepmc.org/abstract/med/19419794
The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription (full-2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02175.x/full
top
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Cannabinoid modulation of neuroinflammatory disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386505/
Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273613/
Cannabinoids and value-based decision making: implications for neurodegenerative disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496267/
The decrease of dopamine D(2)/D(3) receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB(1) cannabinoid receptors in Parkinson’s disease: A preliminary autoradiographic study with the selective dopamine D(2)/D(3) antagonist [(3)H]raclopride and the novel CB(1) inverse agonist
[(125)I]SD7015 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180092/
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Δ(9)-THC exerts a direct neuroprotective effect in a human cell culture model of Parkinson’s disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22236282
Contribution of genetic variants to pain susceptibility in Parkinson disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22473870
Contribution of genetic variants to pain susceptibility in Parkinson disease (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/j.1532-2149.2012.00134.x/abstract
Evaluation of the role of striatal cannabinoid CB1 receptors on movement activity of parkinsonian rats induced by reserpine (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730975/
Striatal Molecular Signature of Subchronic Subthalamic Nucleus High Frequency Stimulation in Parkinsonian Rat (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617149/
Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats (full–2013) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076874
The Influence of Cannabinoids on Generic Traits of Neurodegeneration (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12492/full
top
Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptors activation in mice (full–2013) http://www.sciencedirect.com/science/article/pii/S0278584613001164
A spontaneous deletion of α-Synuclein is associated with an increase in CB1 mRNA transcript and receptor expression in the hippocampus and amygdala: Effects on alcohol consumption (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931467/
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy (full–2013) http://iospress.metapress.com/content/4j61942x88175321/fulltext.html
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829360
Δ9-Tetrahydrocannabinol is protective through PPARγ dependent mitochondrial biogenesis in a cell culture model of Parkinson’s Disease (abst–2013) http://jnnp.bmj.com/content/84/11/e2.58.abstract
Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24140894
The combination of oral L-DOPA/rimonabant for effective dyskinesia treatment and cytological preservation in a rat model of Parkinson’s disease and L-DOPA-induced dyskinesia (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24196024
L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24230991
Neuroactive insecticides: targets, selectivity, resistance, and secondary effects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23317040
The endocannabinoid system: a putative role in neurodegenerative diseases (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226453/
Endocannabinoid signalling and the deteriorating brain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (full–2014) http://www.mdpi.com/1420-3049/19/11/18781/htm
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323744/
Endocannabinoids in Synaptic Plasticity and Neuroprotection (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143501/
Report on Medical Cannabis Research History- What the Science Says (article–2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
L-DOPA disrupts adenosine A2A-cannabinoid CB1-dopamine D2 receptor heteromer  cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies  (abst–2014) http://www.sciencedirect.com/science/article/pii/S0014488614000028
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuro-protection (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23893294
Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental L-DOPA-induced dyskinesia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24599755
Cannabis (Medical Marijuana) Treatment for Motor and Non-Motor Symptoms of Parkinson Disease: An Open-Label Observational Study (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24614667
top
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24845114
The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model (abst–2014)  http://www.neurobiologyofaging.org/article/S0197-4580(14)00384-4/abstract
Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease (abst–2014) http://www.sciencedirect.com/science/article/pii/S0304394014009318
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An  exploratory double-blind trial (abst–2014)  https://www.ncbi.nlm.nih.gov/pubmed/25237116
Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by Parkinson’s Disease Patients in Colorado (full–2015) http://www.hindawi.com/journals/ecam/2015/874849/
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection (full–2015) http://www.molecularneurodegeneration.com/content/pdf/s13024-015-0012-0.pdf
Coordinated Regulation of Synaptic Plasticity at Striatopallidal and Striatonigral Neurons Orchestrates Motor Control (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2901163-8
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease (full-2015) http://www.sciencedirect.com/science/article/pii/S0014488615300583
The therapeutic potential of cannabinoids for movement disorders (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357541/
Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal  ganglia (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13215/full
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe? (full–2015) http://link.springer.com/article/10.1007%2Fs13311-015-0367-5
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From  Preclinical Models to Clinical Applications (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604192/
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in  macaques: changes following experimental parkinsonism (full–2015)  http://link.springer.com/article/10.1007/s00429-014-0823-8
Potential of the cannabinoid CB2 receptor as a pharmacological target against  inflammation in Parkinson’s disease (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0278584615000664
Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function (full–2015) http://www.sciencedirect.com/science/article/pii/S007477421500135X
The role of cannabinoids and leptin in neurological diseases (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25880465
Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson’s disease (abst–2015) http://www.sciencedirect.com/science/article/pii/S0014488615001211
Neuroprotective Effect of JZL184 in MPP+-Treated SH-SY5Y Cells Through CB 2 Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25976369
top

N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Cannabinoids for the Treatment of Movement Disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26206230
Endocannabinoids and Neurodegenerative Disorders: Parkinson’s Disease, Huntington’s Chorea, Alzheimer’s Disease, and Others (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_8 
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815301441
The neuroprotection of cannabidiol against MPP+-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis and might be relevant to Parkinson’s disease (abst–2015) http://www.sciencedirect.com/science/article/pii/S0887233315300047
THC exerts neuroprotective effect in glutamate affected murine primary mesencephalic
cultures and neuroblastoma N18TG2 cells (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1565754
Modulation of cellular redox homeostasis by the endocannabinoid system (full–2016) http://rsob.royalsocietypublishing.org/content/6/4/150276
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10314&path%5B%5D=32486
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00343/full
Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969295/
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892852/
Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165161/
Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816302663
Reversal effect of simvastatin on the decrease in cannabinoid receptor 1 density in 6- hydroxydopamine lesioned rat brains (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27155397
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation driven rat models of Parkinson’s disease (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014488616301790
Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinsons disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27318096
Endocannabionoid System in Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364363
The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27373318
Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action (abst–2016) https://www.researchgate.net/publication/304669756_Coadministration_of_cannabidiol_and_capsazepine_ reduces_L-DOPA-induced_dyskinesia_in_mice_Possible_mechanism_of_action
Type-2 cannabinoid receptors in neurodegeneration (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816306983
Nature of the placebo and nocebo effect in relation to functional neurologic disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27719874
Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson’s disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27723182
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) http://www.eurekaselect.com/146891/article
Pain in Extrapyramidal Neurodegenerative Diseases (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27623111
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target (full–2017)  http://journal.frontiersin.org/article/10.3389/fnins.2017.00030/full
Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a  Murine Model of Parkinson’s Disease Induced by MPTP (full–2017)  http://www.mdpi.com/1424-8247/10/3/60/htm
Cannabinoids in Parkinson’s Disease (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436333 /
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders (full–2017) http://www.cpn.or.kr/journal/view.html?volume=15&number=4&spage=301
Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of
Vascular Dementia (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460147/
AM1241 alleviates MPTP-induced Parkinson’s disease and promotes the regeneration of
DA neurons in PD mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620217/
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders (full–2017) http://www.cpn.or.kr/journal/view.html?volume=15&number=4&spage=301
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues  for other neuroinflammatory diseases (full–2017)  http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference (full–2017)  https://www.nature.com/articles/s41598-017-17796-y
Clinical Evidence for Utilizing Cannabinoids in the Elderly (link to PDF–2017)  https://www.ima.org.il/imaj/viewarticle.aspx?year=2017&month=02&page=71
Effect of inhibition of fatty acid amide hydrolase on MPTP-induced dopaminergic  neuronal damage (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28104279
Cannabinoids therapeutic use: what is our current understanding following the  introduction of THC, THC:CBD oromucosal spray and others? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28276775
Neurotransmission systems in Parkinson’s disease (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28328536
A natural product from Cannabis sativa subsp. sativa inhibits homeodomain-interacting  protein kinase 2 (HIPK2), attenuating MPP+-induced apoptosis in human neuroblastoma  SH-SY5Y cells (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0045206816303972
Neuroprotection in oxidative stress-related neurodegenerative diseases: role of  endocannabinoid system modulation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28497982
GPR3 and GPR6, novel molecular targets for cannabidiol (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0006291X17310744
Zonisamide ameliorates levodopa-induced dyskinesia and reduces expression of striatal  genes in Parkinson model rats (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0168010217300639
Endocannabinoid System in Neurodegenerative Disorders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28608560
Perspectives of Cannabinoid type 2 receptor (CB2R) ligands in neurodegenerative  disorders: Structure Affinity Relationship (SAfiR) and Structure Activity Relationship  (SAR) Studies (abst–2017) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.7b00155
ESSENTIAL DIETARY BIOACTIVE LIPIDS IN NEUROINFLAMMATORY DISEASES (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28637354
AM1241 alleviates MPTP-induced Parkinson’s disease and promotes the regeneration of  DA neurons in PD mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28733540
Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A web-based  investigation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28735833
GPR55: A therapeutic target for Parkinson’s disease? (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817303842
Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and  GDNF expression in a chronic MPTP mouse model of Parkinson’s disease (abst–2017) http://www.sciencedirect.com/science/article/pii/S0197018617301687
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven  neuronal deterioration in experimental Parkinson’s disease: possible involvement of  different binding sites at the PPARγ receptor (full–2018)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771072/
Cannabis in Parkinson’s Disease: Hype or help? (abst in German & English–2018)  https://www.thieme-connect.com/DOI/DOI?10.1055/s-0043-120668
Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression  Alterations in the Basal Ganglia of Patients with Parkinson’s Disease (abst–2018)  https://link.springer.com/article/10.1007%2Fs13311-018-0603-x
top


PATENTS RELATED TO CANNABINOIDS*+
US Patent 7674922 B2 Process for production of delta-9-tetrahydrocannabinol (full–2010) http/www.google.com/patents/US7674922
NEW USE FOR CANNABINOID-CONTAINING PLANT EXTRACTS Patent application number: 20100249223 (full–2010) http/www.faqs.org/patents/app/20100249223
CANNABINOID-CONTAINING PLANT EXTRACTS AS NEUROPROTECTIVE AGENTS Patent application number: 20100239693 (full–2010) http/www.faqs.org/patents/app/20100239693
US Patent Application 20100012118 – Medicament dosage for inhaler (full–2010) http/www.freepatentsonline.com/y2010/0012118.html
Patent 7741365 Peripheral cannabinoid receptor (CB2) selective ligands (full–2010) http://www.freepatentsonline.com/7741365.html
Patent 7816143 Oral detection test for cannabinoid use (full-2010)  http://www.freepatentsonline.com/7816143.html
US Patent Application 20100204312 – METHODS AND COMPOSITIONS FOR TREATING CANCER (full-2010) https://www.google.com/patents/US20100204312
Anti-tumoural effects of cannabinoid combinations – Patent TW201002315 (A) ―
2010-01-16 (full–2010) http://worldwide.espacenet.com/publicationDetails/description?CC=TW&NR=201002315A&KC=A&FT=D&ND=3&date=20100116&DB=EPODOC&locale=en_EP
US Patent Application 20100158973 – THERAPEUTIC USES OF CANNABIDIOL  COMPOUNDS (full–2010) http://www.google.com/patents/US20100158973
CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS Patent application number: 20100016218 (full–2010) http://www.faqs.org/patents/app/20100016218
Patent application title: THERAPEUTIC USES OF CANNABIGEROL (full-2010)  http://www.faqs.org/patents/app/20100292345
US Patent Application 20110097283 – CHEWING GUM COMPOSITIONS COMPRISING CANNABINOIDS (full–2011) http://www.google.com/patents/US20110097283
US Patent 7884133 B2 Cannabidiol derivatives such as 3-(2,6-dihydroxy-4-
pentylphenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics,  antiinflammatory and antidiarrheal agents (full–2011)  https://www.google.com/patents/US7884133?dq=patent+7884133&hl=en&sa=X&ei=Ujb0U_6EEIW5ogSl84LYDg&ved=0CB4Q6AEwAA

US Patent Application 20110052694 – USE OF CANNABIDIOL PRODRUGS IN TOPICAL AND TRANSDERMAL ADMINISTRATION WITH MICRONEEDLES (full–2011) http://www.google.com/patents/US20110052694
US Patent EP 2560512 A1 – Smoke and Odor Elimination Filters, Devices and Methods  (full–2011) http://www.google.com/patents/EP2560512A1?cl=en
US Patent Application 20110020945 – ORAL DETECTION TEST FOR CANNABINOID USE (full–2011) http://www.freshpatents.com/-dt20110127ptan20110020945.php
US Patent Application 20110082195 – NEW USE FOR CANNABINOIDS (full–2011) http://www.faqs.org/patents/app/20110082195
Phytocannabinoids for use in the treatment of cancer – Patent GB2478595 (A) ―
2011-09-14 (full–2011) http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT=D&ND=&date=20110914&DB=&locale=en_EP
Cannabinoid-containing plant extracts as neuroprotective agents – Patent EP2332533 (A1) ― 2011-06-15 (full–2011) http://worldwide.espacenet.com/publicationDetails/description?CC=EP&NR=2332533A1&KC=A1&FT=D&ND=3&date=20110615&DB=EPODOC&locale=en_EP
CANNABIS SATIVA PLANTS RICH IN CANNABICHROMENE AND ITS ACID, EXTRACTS THEREOF AND METHODS OF OBTAINING EXTRACTS THEREFROM (full–2011)  http://www.faqs.org/patents/app/20110098348
Room-temperature stable dronabinol formulations – Patent NZ555701 (A) ― 2011-
05-27 (full–2011) http://worldwide.espacenet.com/publicationDetails/description?CC=NZ&NR=555701A&KC=A&FT=D&ND=3&date=20110527&DB=EPODOC&locale=en_EP

top
NANOENCAPSULATED DELTA-9-TETRAHYDROCANNABINOL – Patent US2012052119 (A1) ― 2012-03-01 (full–2012) http://worldwide.espacenet.com/publicationDetails/description?CC=US&NR=2012052119A1&KC=A1&FT=D&ND=3&date=20120301&DB=EPODOC&locale=en_EP
Controlled cannabis decarboxylation – Patent US2012046352 (A1) ― 2012-02-23 (full–2012) http://worldwide.espacenet.com/publicationDetails/description?CC=US&NR=2012046352A1&KC=A1&FT=D&ND=3&date=20120223&DB=EPODOC&locale=en_EP
TRANSDERMAL DELIVERY OF CANNABINOIDS – Patent US2012034293 (A1)―2012-02-09 (full–2012) http/worldwide.espacenet.com/publicationDetails/description?CC=US&NR=2012034293A1&KC=A1&FT&ND=3&date=20120209&DB=EPODOC&locale=en_EP
Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy: Patent Application 20120004251 (full–2012) http/www.freshpatents.com/-dt20120105ptan20120004251.php
US Patent 8106244 B2 Process for production of delta-9-tetrahydrocannabinol (full–2012) http/www.google.com/patents/US8106244
Topical Compositions with Cannabis Extracts United States Patent Application 20120264818 (full–2012) http/www.freepatentsonline.com/y2012/0264818.html
Herbal medication for cold sores and genital herpes and preparation thereof (full–2012) http://www.google.com/patents/CA2771800A1?cl=en
US Patent Application 20130251824 – Recycling cannabinoid extractor (full–2013) http/www.faqs.org/patents/app/20130251824
US Patent Application 20130245110 – USE FOR CANNABINOIDS (CBD/ THCV for cholesterol control) (full–2013) http/www.freepatentsonline.com/y2013/0245110.html
Transdermal delivery of cannabidiol Patent 8435556 (full–2013) https/www.google.com/patents/US8435556
US Patent Application 20130280343 – Food Products Derived From Cannabinoid-Administered Livestock (full–2013) http/www.freepatentsonline.com/y2013/0280343.html
US Patent Application 20130171145 – METHODS OF TREATING LIVER DISEASE (full–2013) http/www.freepatentsonline.com/y2013/0171145.html
US Patent Application 20130059018 – PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER (full–2013) http/www.google.com/patents/US20130059018
USE FOR CANNABINOIDS (Patent Cholesterol I or II diabetes, obesity, dyslipidaemia, related metabolic disorders and cardiovascular disease -2013) (full–2013) http://www.faqs.org/patents/app/20130245110
Anti-tumoural effects of cannabinoid combinations – US 8632825 B2 (full–2014) https://www.google.com/patents/US8632825?dq=patent+cannabinoid&hl=en&sa=X&ei=M1DyU6KwDYHcOuy6gLgF&ved=0CDMQ6AEwAw
Fatty acid amide hydrolase inhibitors: a patent review (2009 – 2014) (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26413912
Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215781
Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334611
Use of cannabinoids in the treatment of degenerative skeletal muscle diseases:  Applicaton #20170304217 (full–2017) http://www.freshpatents.com/-dt20171026ptan20170304217.php
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017) (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29053063


PERINATAL ASPHYXIA
Therapeutic potential of the endocannabinoid system in perinatal asphyxia (abst in English–2011) http://www.ncbi.nlm.nih.gov/pubmed/22127663 (abst in Spanish) https://www.neurologia.com/articulo/2011157
Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury (abst in English & Japanese-2011) https://link.springer.com/article/10.1007%2Fs12264-011-1008-6
Perinatal asphyxia results in altered expression of the hippocampal acylethanolamide / endocannabinoid signaling system associated to memory impairments in postweaned rats (full–2015) http://journal.frontiersin.org/article/10.3389/fnana.2015.00141/full
New horizons for newborn brain protection: enhancing endogenous neuroprotection (full–2015) http://fn.bmj.com/content/100/6/F541.full.pdf+html
Cannabinoids in Pediatrics (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473390/
top


PERINATAL HYPOXIC-ISCHEMIC INJURY +
Synergistic neuroprotective therapies with hypothermia (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892736/?tool=pubmed
The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia (full–2010) http://stroke.ahajournals.org/content/41/12/2956.long
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic ischemic brain damage in mice is mediated by CB(2) and adenosine receptors (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19900555
Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia ischemia in newborn pigs (full–2011)  http://www.nature.com/pr/journal/v70/n3/pdf/pr2011171a.pdf
The Cannabinoid WIN 55212-2 Mitigates Apoptosis and Mitochondrial Dysfunction After Hypoxia Ischemia (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21909954
Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury (abst in English & Japanese-2011) https://link.springer.com/article/10.1007%2Fs12264-011-1008-6 
Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446851/
Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function (abst–2012)  http://www.sciencedirect.com/science/article/pii/S0028390812002328
Endocannabinoids reduce cerebral damage after hypoxic-ischemic injury in perinatal rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22841538
Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic ischemic brain injury (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146074/
Mechanisms Of Cannabidiol Neuroprotection In Hypoxic-Ischemic Newborn Pigs: Role Of 5HT1A And CB2 Receptors (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0028390813001238
Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuro-inflammation and apoptosis after neonatal ischemic brain damage (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23376684
Cannabinoids: well-suited candidates for the treatment of perinatal brain injury (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061885/
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707667/
top
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From  Preclinical Models to Clinical Applications (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604192/
New horizons for newborn brain protection: enhancing endogenous neuroprotection (full–2015) http://fn.bmj.com/content/early/2015/06/10/archdischild-2014-306284.long
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following
germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815001574
Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940392/
Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27441365
Neuroprotective Effects of Cannabidiol In Hypoxic Ischemic Insult: The Therapeutic Window In Newborn Mice (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27686886
Cannabinoids in Pediatrics (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473390/


PERIPHERAL NERVOUS SYSTEM
Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a
model of murine type I diabetic peripheral neuropathic pain (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845559/?tool=pmcentrez
Spinal and peripheral analgesic effects of the CB cannabinoid receptor agonist AM1241  in two models of bone cancer-induced pain (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931557/?tool=pubmed
Rehashing endocannabinoid antagonists: can we selectively target the periphery to safely treat obesity and type 2 diabetes? (full–2010)  http://www.jci.org/articles/view/44099?search%5Babstract_text%5D=&search%5Barticle_text%5D=cannabinoid&search%5Bauthors_text%5D=&search%5Bfpage%5D=&search%5Btitle_text%5D=&search%5Bvolume%5D=
Central and peripheral consequences of the chronic blockade of CB1 cannabinoid  receptor with rimonabant or taranabant (full–2010)  http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2009.06549.x/full
Peripheral cannabinoid type 2 receptor regulates osteoclast formation, MDA-MB-231  breast cancer cell migration and bone marrow/tumour cell interaction via PI3 kinase/AKT and P38 pathways (abst–2010) http://www.thebonejournal.com/article/S8756-3282%2810%2901828-4/abstract
An Open-Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or  Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral  Neuropathy (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=311
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical  hyperalgesia in a model of bone cancer pain (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104059/
The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is  suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling  in models of chemotherapy-induced peripheral neuropathy (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502129/
An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22921260
Epigenetic Regulation of Genes that Modulate Chronic Stress-induced Visceral Pain in the Peripheral Nervous System (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274248/
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral  neuropathy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268146/
Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine  model of chemotherapy-induced peripheral neuropathy (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346731/
Cannabidiol and endogenous opioid peptide-mediated mechanisms modulate  antinociception induced by transcutaneous electrostimulation of the peripheral nervous  system (abst–2014) http://www.jns-journal.com/article/S0022-510X(14)00603-0/fulltext
Cognitive performance and peripheral endocannabinoid system receptor expression in  schizophrenia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24853061
Genetic dissection of the endocannabinoid system and how it changed our knowledge of
cannabinoid pharmacology and mammalian physiology (abst–2014)  http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch4/summary
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in
visceral and somatosensory pain regulatory pathways (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0014488615300959
Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical  development of new perspectives (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26058312
Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979564/
Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of
memory consolidation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024630/
Inflammation of peripheral tissues and injury to peripheral nerves induce diferring effects in the expression of the calcium-sensitive anandamide-synthesising enzyme and related molecules in rat primary sensory neurons (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27997038
Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced  epileptic seizures in mice via quantitative mass spectrometry (abst–2016)  http://www.sciencedirect.com/science/article/pii/S1388198116303092
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune  interactions (abst–2016) http://www.eurekaselect.com/138448/article
PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and  cannabinoid receptors and inhibition of neutral endopeptidase (abst–2016)  http://onlinelibrary.wiley.com/doi/10.1111/bph.13448/abstract
Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and  peripheral nervous system (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0181064
Early blockade of joint inflammation with a fatty acid amide hydrolase inhibitor  decreases end-stage osteoarthritis pain and peripheral neuropathy in mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445456/
Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and  central mechanisms (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407663/
Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to  cannabinoid-induced effects (full–2017)  http://www.sciencedirect.com/science/article/pii/S0024320517306069?via%3Dihub
Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral  type 2 cannabinoid receptor (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1043661816313809
Peripheral inflammation alters N-arachidonoylphosphatidylethanolamine (20:4-NAPE)  induced modulation of nociceptive spinal cord synaptic transmission (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28476070
Acetaminophen Relieves Inflammatory Pain Through CB1 Cannabinoid Receptors in the  Rostral Ventromedial Medulla (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29167401


PHANTOM LIMB SYNDROME +
MMJ vs Phantom Limb Pain (interview–2016) https://www.hellomd.com/health-wellness/5818cc787d130e000740091d/how-i-stopped-my-phantom-limb-pain
Mechanisms and treatment of painful neuromas (full–2018)  https://www.degruyter.com/view/j/revneuro.ahead-of-print/revneuro-2017-0077/revneuro-2017-0077.xml


PHARC/POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA and CATARACT SYNDROME
Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933347/?tool=pmcentrez
The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2‐arachidonoylglycerol signalling through cannabinoid receptors (full–2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1748-1716.2011.02280.x/full
Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3 (full–2012) http/www.ojrd.com/content/7/1/59
ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557017/
Two Novel Mutations in ABHD12: Expansion of the Mutation Spectrum in PHARC and Assessment of Their Functional Effects (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855015/
Discovery of triterpenoids as reversible inhibitors of α/β-hydrolase domain containing 12 (ABHD12) (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045134/
Exome sequencing extends the phenotypic spectrum for ABHD12 mutations: from syndromic to nonsyndromic retinal degeneration (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24697911
Functional validation of ABHD12 mutations in the neurodegenerative disease PHARC (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27890673


PHOTOBIOMODULATION/LOW LEVEL LASAR THERAPY (LLLT) 
Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role  of Cannabinoid Receptors/ATP-Sensitive K+ Channel/p38-MAPK Signalling Pathway (abst–2017) https://link.springer.com/article/10.1007%2Fs12035-017-0792-z


PLACEBO EFFECT
Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21963514
Placebo-induced improvements: how therapeutic rituals affect the patient’s brain (full–2012) http://www.jams-kpi.com/article/S2005-2901%2812%2900031-3/fulltext
The Neurobiology of Placebo and Nocebo: How Expectations Influence Treatment Outcomes (full–2013)  http://neuro.psychiatryonline.org/doi/full/10.1176/appi.neuropsych.13090207
FAAH selectively influences placebo effects (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24042479
Molecular mechanisms of placebo responses in humans (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372496/
Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclo-oxygenase-prostaglandins pathway (full–2014) https://iris.unito.it/retrieve/handle/2318/151583/126369/Benedetti_Pain_2014_OA.pdf
top
The sweetest pill to swallow: How patient neurobiology can be harnessed to maximise placebo effects (abst–2014) http://www.sciencedirect.com/science/article/pii/S0149763413002157
Cannabinoids and Epilepsy (full–2015) http://link.springer.com/article/10.1007%2Fs13311-015-0375-5
Placebo and nocebo effects: a complex interplay between psychological factors and neurochemical networks (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25928679
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the  Treatment of Neuropathic Pain from Spinal Cord Injury and Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007175/

Placebos: Honest fakery (article–2016)  http://www.nature.com/nature/journal/v535/n7611_supp/full/535S14a.html
Placebo effect: clinical, biological and therapeutical involvements in depression (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26879253
Nature of the placebo and nocebo effect in relation to functional neurologic disorders  (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27719874
The Placebo Effect in Cardiology: Understanding and Using It (full in English, abst in French–2017) http://www.onlinecjc.ca/article/S0828-282X(17)31036-X/fulltext
Placebo Effects of Edible Cannabis: Reported Intoxication Effects at a 30-Minute Delay (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28771093
Mechanisms of placebo analgesia: A dual-process model informed by insights from cross-species comparisons (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0301008217300011?via%3Dihub


POISONING-HEAVY METAL*+
Nutritive quality of romanian hemp varieties (Cannabis sativa L.) with special focus on
oil and metal contents of seeds (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543203/
Protective effect of cannabidiol against cadmium hepatotoxicity in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23993482
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296873
Arsenic decreases antinociceptive activity of paracetamol: Possible involvement of serotonergic and endocannabinoid receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25128769
Effective Phytoextraction of Cadmium (Cd) with Increasing Concentration of Total Phenolics and Free Proline in Cannabis sativa (L) Plant Under Various Treatments of Fertilizers, Plant Growth Regulators and Sodium Salt (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25174425
Differential effects and potential adverse outcomes of ionic silver and silver nanoparticles in vivo and in vitro (abst–2014) http://pubs.acs.org/doi/abs/10.1021/es4042258
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503701/
Phytoaccumulation of Heavy Metals in Natural Vegetation at the Municipal Wastewater  Site in Abbottabad, Pakistan (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26366840
Thallium-Induced Toxicity in Rat Brain Crude Synaptosomal/Mitochondrial Fractions is  Sensitive to Anti-excitatory and Antioxidant Agents (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29313218


POISONING-ORGANOPHOSPHATE +
Behavioral sequelae following acute diisopropylfluorophosphate intoxication in rats: comparative effects of atropine and cannabinomimetics (full–2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2854260/?toolubmed
Cannabinoid Receptor Agonist WIN-55,212-2 Protects Differentiated PC12 Cells From Organophosphorus- Induced Apoptosis (full–2010)  http://journals.sagepub.com/doi/full/10.1177/1091581809359708
Activity-based protein profiling of organophosphorus and thiocarbamate pesticides reveals multiple serine hydrolase targets in mouse brain (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3071868/
Comparative effects of chlorpyrifos in wild type and cannabinoid Cb1 receptor knockout mice (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3205254/
Effect of Developmental Chlorpyrifos Exposure on Endocannabinoid Metabolizing Enzymes in the Brain of Juvenile Rats (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3143466/
top
Inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by chlorpyrifos oxon, paraoxon and methyl paraoxon (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3345137/
Acetaminophen, pesticide, and diethylhexyl phthalate metabolites, anandamide, and fatty acids in deciduous molars: potential biomarkers of perinatal exposure (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22805989
Induction of Endocannabinoid Levels in Juvenile Rat Brain Following Developmental Chlorpyrifos Exposure (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954109/
Comparative effects of parathion and chlorpyrifos on extracellular endocannabinoid levels in rat hippocampus: Influence on cholinergic toxicity (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831619/
Low Level Chlorpyrifos Exposure Increases Anandamide Accumulation in Juvenile Rat Brain in the Absence of Brain Cholinesterase Inhibition (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071163/
Neuroactive insecticides: targets, selectivity, resistance, and secondary effects (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23317040
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23296873
The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448943/
Organophosphate agents induce plasma hypertriglyceridemia in mouse via single or dual inhibition of the endocannabinoid hydrolyzing enzyme(s) (abst–2014)
http://www.sciencedirect.com/science/article/pii/S0378427413014604
Fenitrothion action at the endocannabinoid system leading to spermatotoxicity in Wistar rats (abst–2014) http://www.sciencedirect.com/science/article/pii/S0041008X1400252X
Muscarinic M1 receptor and cannabinoid CB1 receptor do not modulate paraoxon induced seizures (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317231/
Comparative effects of parathion and chlorpyrifos on endocannabinoid and  endocannabinoid-like lipid metabolites in rat striatum (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0161813X15001138
Decreased anxiety in juvenile rats following exposure to low levels of chlorpyrifos during development (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0161813X15300322
Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo  Neurotoxic Effects of Paraoxon (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28803438
Inhibition of Endocannabinoid-Metabolizing Enzymes in Peripheral Tissues Following  Developmental Chlorpyrifos Exposure in Rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28820005
Effects of acute exposure to chlorpyrifos on cholinergic and non-cholinergic targets in  normal and high-fat fed male C57BL/6J mice (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0041008X17304295?via%3Dihub
top


POISONING-OTHER
Determination of Herbicides Paraquat, Glyphosate, and Aminomethylphosphonic Acid in Marijuana Samples by Capillary Electrophoresis (abst–2014)  http://onlinelibrary.wiley.com/doi/10.1111/1556-4029.12628/full
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain (abst–2017)
http://www.sciencedirect.com/science/article/pii/S1001074216302340
URB597 reduces biochemical, behavioral and morphological alterations in two  neurotoxic models in rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28157650


POISONING-PARAQUAT*+
Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/20514518
CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat (full–2014) http/www.hindawi.com/journals/bmri/2014/971750/
Determination of Herbicides Paraquat, Glyphosate, and Aminomethylphosphonic Acid in Marijuana Samples by Capillary Electrophoresis (abst–2014) http://onlinelibrary.wiley.com/doi/10.1111/1556-4029.12628/full


POISONING–ROTENONE
Phytocannabinoids tetrahydrocannabinol and cannabidiol act against rotenone induced damages in murine cell cultures (abst–2012) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1320529
The effect of cannabis on oxidative stress and neurodegeneration induced by intrastriatal rotenone injection in rats (abst–2015) http://link.springer.com/article/10.1007/s00580-014-1907-9
Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969295/
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation driven rat models of Parkinson’s disease (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0014488616301790


POLLS, SURVEYS and QUESTIONAIRES +
Survey on the use of psychotropic drugs by twelve military police units in the municipalities of Goiânia and Aparecida de Goiânia, state of Goiás, Brazil (full–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000400012&lng=en&nrm=iso&tlng=en
Do patients think cannabis causes schizophrenia? – A qualitative study on the causal
beliefs of cannabis using patients with schizophrenia (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954921/?tool=pmcentrez
Reasons for illicit drug use in people with schizophrenia: Qualitative study (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999587/?tool=pubmed
Survey of alcohol, tobacco, and cannabis use in the French army (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20390703
Attraction to cannabis among men with schizophrenia: a phenomenological study (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20420097
An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in  California (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673028/
Obesity and Cannabis Use: Results From 2 Representative National Surveys (full–2011) http://aje.oxfordjournals.org/content/early/2011/08/24/aje.kwr200.full
The Use of Marijuana or Synthetic Cannabinoids for the Treatment of Headache (1st page–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2011.01848.x/abstract
Posttraumatic stress disorder and Cannabis use in a nationally representative sample (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21480682
Marijuana use among older adults in the U.S.A.: user characteristics, patterns of use, and
implications for intervention (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21108863
Assessment of hospice health professionals’ knowledge, views, and experience with  medical marijuana (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22077541
The medicinal use of cannabis and cannabinoids: an international survey on methods of
intake (abst–2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=482
Profile of Psychoactive Substances Consumption in Workplace (abst in French & English–2011) https://www.journal-therapie.org/articles/therapie/abs/2011/02/th111929/th111929.html
Prevalence and co-use of marijuana among young adult cigarette smokers: An  anonymous online national survey (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507655/
Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients (full–2012) https://philippelucasvictoria.files.wordpress.com/2012/12/rx-mj-as-a-substitute-for-aod-addiction-researchand-theory-2012-in-press.pdf
Prospectively Surveying Health-Related Quality of Life and Symptom Relief in a Lot Based Sample of Medical Cannabis-Using Patients in Urban Washington State Reveals Managed Chronic Illness and Debility (full–2012) http://journals.sagepub.com/doi/full/10.1177/1049909112454215
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22784399
Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107777/
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment resistant epilepsy (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157067/
top
Identity formation, marijuana and “the self”: a study of cannabis normalization among university students (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847659/
Statistics on cannabis users skew perceptions of cannabis use (full–2013)  http://journal.frontiersin.org/article/10.3389/fpsyt.2013.00138/full
The impact of marijuana use on glucose, insulin, and insulin resistance among US adults  (full–2013) http://www.amjmed.com/article/S0002-9343%2813%2900200-3/fulltext
The New Politics of Marijuana Legalization: Why Opinion is Changing (full–2013) http://www.brookings.edu/research/papers/2013/05/29-politics-marijuana-legalization-galston-dionne
Colorado family physicians’ attitudes toward medical marijuana (full–2013)  http://www.jabfm.org/content/26/1/52.long
Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use  (full–2013) http://www.ijdp.org/article/S0955-3959%2813%2900135-7/fulltext
Emergency Physicians’ Knowledge of Cannabinoid Designer Drugs (full–2013)  http://escholarship.org/uc/item/9mk2951f#
Psychoactive substances-Some new, some old: A scan of the situation in the U.S. (full–2013) http://www.drugandalcoholdependence.com/article/S0376-8716%2813%2900373-6/fulltext
Clinical decisions. Medicinal use of marijuana–polling results (article–2013)  http://www.nejm.org/doi/full/10.1056/NEJMclde1305159
The medicinal use of cannabis and cannabinoids-an international cross-sectional survey on administration forms (abst–2013) http://www.unboundmedicine.com/medline/citation/24175484/The_medicinal_use_of_cannabis_and_cannabinoids–an_international_cross-sectional_survey_on_administration_forms
Lifetime prevalence of alcohol and substance use in Egypt: a community survey (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23577901
Characteristics of adults seeking medical marijuana certification (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23683791
Distress, Coping, and Drug Law Enforcement in a Series of Patients Using Medical  Cannabis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23538974
Therapeutic benefits of cannabis: a patient survey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
A survey of synthetic cannabinoid consumption by current cannabis users (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048873/
Health Poll – Legalizing Marijuana (full–2014) http://truvenhealth.com/Portals/0/NPR-Truven-HealthPoll/TRU_13728_0414_NPRPulseMarijuanaStudy.pdf
Synthetic Cannabinoids: Use and predictors in a Community Sample of Young Adults  (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362955/
Drug use, consequences and perceived accessibility in three Nigerian universities (full–2014) http://file.scirp.org/Html/9-1420229_41669.htm
An Internet survey of marijuana and hot shower use in adults with cyclic vomiting  syndrome (CVS) (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641512/
Cannabis use in relation to obesity and insulin resistance in the inuit population (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/oby.20973/full
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Prevalence of medical marijuana use in California, 2012 (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25255903
Preferences for policy options for cannabis in an Australian general population: A  discrete choice experiment (abst–2014) http://www.ijdp.org/article/S0955-3959(14)00066-8/fulltext
Longitudinal associations between social anxiety symptoms and cannabis use throughout adolescence: the role of peer involvement (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854944/

Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys (full–2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630811/

A survey of cannabis (marijuana) use and self-reported benefit in men with chronic prostatitis/chronic pelvic pain syndrome (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277530/
Drugs and Crime Facts (full–2015) http://www.bjs.gov/content/dcf/ptrpa.cfm
Cannabis in medicine: a national educational needs assessment among Canadian physicians (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374299/
State Estimates of Adolescent Marijuana Use and Perceptions of Risk of Harm From Marijuana Use: 2013 and 2014 (full–2015) http://www.samhsa.gov/data/sites/default/files/report_2121/ShortReport-2121.html
Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Témiscamingue region of Quebec (full–2015) http://cmajopen.ca/content/3/2/E251.full?sid=139f05c1-b441-476b-99ff-addf8c918e1a
top
High School Students’ Use of Electronic Cigarettes to Vaporize Cannabis (full–2015) http://pediatrics.aappublications.org/content/136/4/611.long
Synthetic cannabinoid use in a nationally representative sample of US high school seniors (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361370/
Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race/ethnicity (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361312/
ADOLESCENTS’ USE OF MEDICAL MARIJUANA: A SECONDARY ANALYSIS OF MONITORING THE FUTURE DATA (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514911/
Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent  under-reporting (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633323/
Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014 (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767576/
Longitudinal Effects of School Drug Policies on Student Marijuana Use in Washington State and Victoria, Australia (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386529/
A safer alternative: Cannabis substitution as harm reduction (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25919477
In the weeds: a baseline view of cannabis use among legalizing states and their neighbours (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216038/
Cannabis use, depression and anxiety: A 3-year prospective population-based study (full-2015) http://www.jad-journal.com/article/S0165-0327(15)31030-2/fulltext
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution
Experience (full–2015) http://www.jpsmjournal.com/article/S0885-3924(14)00312-1/fulltext
Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by  Parkinson’s Disease Patients in Colorado (full–2015)  http://www.hindawi.com/journals/ecam/2015/874849/
The Use of Marijuana and Hydroxyurea Among Sickle Cell Patients (full–2015)  http://www.bloodjournal.org/content/128/22/5913?sso-checked=true
Substance Use among Medical Students: A Literature Review 1988- 2013 (full download in English, abst in Spanish–2015)  http://www.actaspsiquiatria.es/repositorio//17/95/ENG/17-95-ENG-109-21-286815.pdf
Assessment of Israeli Physicians’ Knowledge, Experience and Attitudes towards Medical  Cannabis: A Pilot Study (link to PDF–2015) http://www.ima.org.il/IMAJ/ViewArticle.aspx?year=2015&month=07&page=437
Canadian Tobacco Alcohol and Drugs (CTADS): 2013 summary (summary–2015)  https://www.canada.ca/en/health-canada/services/canadian-tobacco-alcohol-drugs-survey/2013-summary.html
The use of illicit drugs as self-medication in the treatment of cluster headache: Results  from an Italian online survey (abst–2015)  http://journals.sagepub.com/doi/full/10.1177/0333102415583145
Medicinal Cannabis: A Survey Among Health Care Providers in Washington State (abst–2015) http://journals.sagepub.com/doi/full/10.1177/1049909115604669
Change in perceived risk associated with marijuana use in the United States from 2002 to
2012 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25646638
Profiles of medicinal cannabis patients attending compassion centers in rhode island  (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715068
A safer alternative: Cannabis substitution as harm reduction (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25919477
Novel psychoactive substance use by US adolescents: Characteristics associated with use  of synthetic cannabinoids and synthetic cathinones (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26711540
Legal issues for German-speaking cannabis growers. Results from an online survey  (abst–2015) http://www.ijdp.org/article/S0955-3959%2815%2900315-1/abstract
Sexual identity and prevalence of alcohol and other drug use among Australians in the  general population (abst–2015) http://www.ijdp.org/article/S0955-3959(15)00347-3/abstract
CANNABIS: ALTERNATIVE REALITIES (CRA) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26650405
Past 15-year trends in adolescent marijuana use: Differences by race/ethnicity and sex (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26361714
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26422462
Online survey characterizing vaporizer use among cannabis users (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2901835-9/abstract
Marijuana experiences, voting behaviors, and early perspectives regarding marijuana legalization among college students from 2 states (abst–2015) http://www.tandfonline.com/doi/full/10.1080/07448481.2015.1062769?src=recsys
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric  epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935511
The Impact of Legalizing and Regulating Weed: Issues with Study Design and Emerging  Findings in the USA (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26718590
A longitudinal study of cannabis use initiation among high school students: Effects of  social anxiety, expectancies, peers and alcohol (abst–2015)  https://www.ncbi.nlm.nih.gov/pubmed/25800726
Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey (full–2016) http://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-016-0746-4
Genome-wide association study of lifetime cannabis use based on a large meta-analytic  sample of 32 330 subjects from the International Cannabis Consortium (full–2016)  http://www.nature.com/tp/journal/v6/n3/full/tp201636a.html
The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists’ Perspectives (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155113
Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for  Rheumatic Disorders (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839539/
top
Drug abuse in slum population (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776588/
Socio-Demographic Factors Associated with Psychoactive Substance Use among Commercial Motorcycle Operators in Kano, Nigeria (full–2016) http://file.scirp.org/Html/9-1420373_62853.htm
National Estimates of Marijuana Use and Related Indicators – National Survey on Drug Use and Health, United States, 2002–2014 (full–2016) http://www.cdc.gov/mmwr/volumes/65/ss/ss6511a1.htm?s_cid=ss6511a1_e
Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug Related Emergency Department Visits (full–2016) http://www.ncbi.nlm.nih.gov/books/NBK384680/
Effectiveness of the synthetic cannabinoids seminar (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121273/
Minnesota Pharmacists and Medical Cannabis: A Survey of Knowledge, Concerns, and Interest Prior to Program Launch (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083080/
Opinions of Hospital Pharmacists in Canada Regarding Marijuana for Medical Purposes (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853179/
Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of  National Health and Nutrition Examination Survey Data (full–2016)
http://www.amjmed.com/article/S0002-9343(15)01024-4/fulltext
The widening gender gap in marijuana use prevalence in the U.S. during a period of  economic change, 2002-2014 (full–2016)  http://www.drugandalcoholdependence.com/article/S0376-8716(16)30994-2/fulltext
Comparison of outcome expectancies for synthetic cannabinoids and botanical marijuana (full–2016) http://www.tandfonline.com/doi/full/10.3109/00952990.2015.1135158
American Attitudes toward Substance Use in the United States (link to PDF–2016) http://www.apnorc.org/projects/Pages/american-attitudes-toward-substance-use-in-the-united-states.aspx
COMPREHENSIVE MEDICAL MARIJUANA PATIENT STUDY (link to PDF–2016) https://www.hellomd.com/medical-marijuana-patient-survey
Working on a Standard Joint Unit: A pilot test (link to download in English, abst in Spanish–2016) http://www.adicciones.es/index.php/adicciones/article/download/721/808
Marijuana: Views on Its Medical Use Recorded at the Slovak Social Network (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27282988
Prioritizing Alcohol Prevention: Establishing Alcohol as the Gateway Drug and Linking  Age of First Drink With Illicit Drug Use (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/26645418
Drug abuse in nursing students (abst in Spanish & English–2016)  http://www.elsevier.es/es-revista-enfermeria-clinica-35-articulo-consumo-drogas-estudiantes-enfermeria-S1130862115001837
Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262964
Traffic accidentability and risky driving behavior in young people in New Caledonia Results of study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27259836
Pediatric oncology providers and use of medical marijuana in children with cancer (abst–2016) http://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.10581
New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27349158
The association between cannabis use and anxiety disorders: Results from a population based representative sample (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26775742
Cannabis for Cognitive Enhancement as a New Coping Strategy? Results From a Survey  of Students at Four Universities in Germany (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27607062
A comparison between wastewater-based drug data and an illicit drug use survey in a selected community (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27450319 Integrating environmental and self-report data to refine cannabis prevalence estimates in a major urban area of Switzerland (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27455466
Early Survey Results from the Minnesota Medical Cannabis Program (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27464390
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: A survey of preferences, attitudes and beliefs among patients willing to consider participation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27530738
Risky substance use and peer pressure in Swiss young men: Test of moderation effects (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27632359
The replicability of cannabis use prevalence estimates in the United States (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27658846
Bongs and baby boomers: Trends in cannabis use among older Australians (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27730759
Determining Cannabis Use Status From a Photograph: An Assessment of the “Jay-dar” in Neuropsychologists (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27779445
Pseudo-Underage Assessment of Compliance With Identification Regulations at Retail Marijuana Outlets in Colorado (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27797687
Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27842047
Got Munchies? Estimating the Relationship between Marijuana Use and Body Mass Index (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27572145
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis (abst–2016) http://www.msard-journal.com/article/S2211-0348(16)30171-7/fulltext
Demographic trends among older cannabis users in the United States, 2006–13 (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27767235
The association between cannabis use and motivation and intentions to quit tobacco within a sample of Australian socioeconomically disadvantaged smokers (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27923866
Is the Legalization of Marijuana Associated With Its Use by Adolescents? (abst–2016) http://www.tandfonline.com/doi/full/10.1080/10826084.2016.1223139?src=recsys
Attitudes towards drug policies in Latin America: Results from a Latin-American Survey (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27988428
Substance Use, Health, and Functioning Characteristics of Medical Marijuana Program Participants Compared to the General Adult Population in Ontario (Canada) (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28001910
Population surveys compared with wastewater analysis for monitoring illicit drug  consumption in Italy in 2010-2014 (abst–2016)  http://www.drugandalcoholdependence.com/article/S0376-8716(16)00062-4/fulltext
Medical cannabis associated with decreased opiate medication use in retrospective crosssectional survey of chronic pain patients (abst–2016)  http://www.jpain.org/article/S1526-5900(16)00567-8/fulltext
Relationship Between Frequent Recreational Cannabis (Marijuana and Hashish) Use and
Periodontitis in Adults in the United States: Nhanes 2011-12 (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27718772
Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey (full–2017) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0129-7
Medical use of cannabis in Switzerland: analysis of approved exceptional licences (full–2017) https://smw.ch/article/doi/smw.2017.14463
Understanding Patients’ Process to Use Medical Marijuana: A Southern New Jersey  Community Engagement Project (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513646/
Newly incident cannabis use in the United States, 2002-2011: a regional and state level  benchmark (full–2017) https://peerj.com/articles/3616/
Prevalence and correlates of treatment utilization among adults with cannabis use  disorder in the United States (full–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30228-4/fulltext
An Australian nationwide survey on medicinal cannabis use for epilepsy: History of  antiepileptic drug treatment predicts medicinal cannabis use (full–2017)  http://www.epilepsybehavior.com/article/S1525-5050(17)30073-2/fulltext
Measuring cannabis consumption: Psychometric properties of the Daily Sessions,  Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU) (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446174/
Training and Practices of Cannabis Dispensary Staff (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531366/
Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569620/
Synthetic Cannabinoid Use Among High School Seniors (full–2017)  http://pediatrics.aappublications.org/content/early/2017/09/07/peds.2017-1330.long
Cannabis use among patients at a comprehensive cancer center in a state with legalized  medicinal and recreational use (full–2017)  http://onlinelibrary.wiley.com/doi/10.1002/cncr.30879/full
Physicians-in-training are not prepared to prescribe medical marijuana (full–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30441-6/fulltext
Cannabis use in persons with traumatic spinal cord injury in Denmark (link to PDF- 2017) https://www.medicaljournals.se/jrm/content/abstract/10.2340/16501977-2105
Are dispensaries indispensable? Patient experiences of access to cannabis from medical
cannabis dispensaries in Canada (full-2017) http://www.ijdp.org/article/S0955-3959(17)30150-0/fulltext
Illicit drug policy in Spain: the opinion of health and legal professionals (abst in Spanish, link to PDF in English-2017)  http://www.adicciones.es/index.php/adicciones/article/view/810
Experts’ Perspectives on the Role of Medical Marijuana in Oncology: a semi-structured interview study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28040884
Support for Marijuana Legalization and Predictors of Intentions to Use Marijuana More Often in Response to Legalization Among U.S. Young Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/27976988
Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28107687
Development and validation of the cannabis experiences questionnaire – Intoxication  effects checklist (CEQ-I) short form (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28189531
Psychometric Properties of the Turkish Versions of the Cannabis Use Problems  Identification Test (CUPIT) and the Adult Cannabis Problems Questionnaire (CPQ) (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28195831
Public perceptions of arguments supporting and opposing recreational marijuana  legalization (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28189806
Cannabis use and bone mineral density: NHANES 2007–2010 (abst–2017)  http://link.springer.com/article/10.1007%2Fs11657-017-0320-9
Medical cannabis access, use, and substitution for prescription opioids and other  substances: A survey of authorized medical cannabis patients (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28189912
Chronic Pain Patients’ Perspectives of Medical Cannabis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28328576
Cannabis use and the course and outcome of major depressive disorder: A population  based longitudinal study (abst–2017) http://www.psy-journal.com/article/S0165-1781(16)31187-8/abstract
Cannabis use and mental health-related quality of life among individuals with depressive disorders (abst–2017) http://www.psy-journal.com/article/S0165-1781(15)30306-1/fulltext
Demographic Characteristics, Components of Sexuality and Gender, and Minority Stress  and Their Associations to Excessive Alcohol, Cannabis, and Illicit (Noncannabis) Drug  Use Among a Large Sample of Transgender People in the United States (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28405831
Explaining the declining rates of past year cannabis use in Australia: A first pass (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28439990
Support for marijuana legalization in the US state of Washington has continued to  increase through 2016 (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30171-0/fulltext
The Cannabis Information Helpline: Assessing Interest in the Medicinal Use of Cannabis  in Australia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28557590
Comparing Medical and Recreational Cannabis Users on Socio-Demographic, Substance  and Medication Use, and Health and Disability Characteristics (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28595191
Attitudes Toward Medical Cannabis Legalization Among Serbian Medical Students (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605305
Associations of Bullying and Cyberbullying With Substance Use and Sexual Risk Taking  in Young Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605163
Loose regulation of medical marijuana programs associated with higher rates of adult  marijuana use but not cannabis use disorder (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28600874
Ready, willing, and able: The role of cannabis use opportunities in understanding  adolescent cannabis use (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28600881
User characteristics and effect profile of Butane Hash Oil: An extremely high-potency  cannabis concentrate (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30255-7/fulltext
Medical Cannabis in Serbia: The Survey of Knowledge and Attitudes in an Urban Adult  Population (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28632077
U.S. cannabis legalization and use of vaping and edible products among youth (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30184-9/fulltext
Cannabis Use and Cannabis Use Disorders Among Youth in the United States, 2002-
2014 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28686820
Exposure to and Content of Marijuana Product Reviews (abst–2017)  https://link.springer.com/article/10.1007%2Fs11121-017-0818-9
Association between Nonmedical Marijuana and Pain Reliever Uses among Individuals  Aged 50 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28699829
Characterizing marijuana concentrate users: A web-based survey (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30311-3/fulltext
Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A web-based  investigation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28735833
Perioperative Patient Beliefs Regarding Potential Effectiveness of Marijuana  (Cannabinoids) for Treatment of Pain: A Prospective Population Survey (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28796754
Driving under the influence of drugs: Perceptions and attitudes of New Zealand drivers  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28554064
A Cloud on the Horizon – A survey into the use of electronic vaping devices for  recreational drug and new psychoactive substance (NPS) administration (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29025078
Knowledge, Skills, and Attitudes Regarding the Use of Medical Cannabis in the Hospice  Population: An Educational Intervention (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29121790
Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29185555
Prevalence of illicit drug use at the end of pregnancy: a cross-sectional study at the time  of birth (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28176511
Marijuana and tobacco co-use among a nationally representative sample of US pregnant  and non-pregnant women: 2005-2014 National Survey on Drug Use and Health findings  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28599211
Motivational changes of cannabis use prior to and during the course of schizophrenia  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28004866
A prospective observational study of problematic oral cannabinoid use (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4811-6
Investigating the relationships between alcohol consumption, cannabis use and  circulating cytokines: a preliminary analysis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29286537
Smartphone-based ecological momentary assessment (EMA) of alcohol and cannabis use  in older adults with and without HIV infection (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0306460317303878?via%3Dihub
Cannabis use disorder and male sex predict medical cannabis card status in a sample of  high risk adolescents (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30562-8/fulltext
Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis (abst–2017) https://link.springer.com/article/10.1007%2Fs00415-017-8715-5
Marijuana use is associated with hypersensitivity to multiple allergens in US adults (full–2018) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30555-0/fulltext
The Prevalence of Cannabinoid Hyperemesis Syndrome Among Regular Marijuana  Smokers in an Urban Public Hospital (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29327809
Trends in Daily Cannabis Use Among Cigarette Smokers: United States, 2002-2014 (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29161058
Exposure to Marijuana Marketing After Legalization of Retail Sales: Oregonians’  Experiences, 2015-2016 (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29161062
Characterizing Blunt Smokers by Their Acquisition of Cannabis (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29300122
Don’t Judge a Book by its Cover: Examiner Expectancy Effects Predict Neuropsychological Performance for Individuals Judged as Chronic Cannabis Users (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29342226
Prevalence of problematic cannabis use in Canada: Cross-sectional findings from the  2013 Canadian Tobacco, Alcohol and Drugs Survey (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29356658


POLLUTION/ENVIRONMENT
Drugs of abuse in airborne particulates in urban environments (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/20447692/abstract/Drugs_of_abuse_in_airborne_particulates_in_urban_environments_
Potential exposures associated with indoor marijuana growing operations (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24116667
Cannabis, Pesticides and Conflicting Laws: the Dilemma for Legalized States and Implications for Public Health (abst–2014) http://www.sciencedirect.com/science/article/pii/S027323001400097X
Effective Phytoextraction of Cadmium (Cd) with Increasing Concentration of Total Phenolics and Free Proline in Cannabis sativa (L) Plant Under Various Treatments of Fertilizers, Plant Growth Regulators and Sodium Salt (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25174425
Impacts of surface water diversions for marijuana cultivation on aquatic habitat in four northwestern California watersheds (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0120016
Patterns of Natural and Human-Caused Mortality Factors of a Rare Forest Carnivore, the Fisher (Pekania pennanti) in California (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633177/
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503701/
Phytoaccumulation of Heavy Metals in Natural Vegetation at the Municipal Wastewater Site in Abbottabad, Pakistan (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26366840
High Time for Conservation: Adding the Environment to the Debate on Marijuana Liberalization (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776720/
The increase of cannabis use may indirectly affect the health status of a freshwater species (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27496769
Phytoextraction of heavy metals by potential native plants and their microscopic observation of root growing on stabilised distillery sludge as a prospective tool for in situ phytoremediation of industrial waste (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27826829
High Time to Assess the Environmental Impacts of Cannabis Cultivation (full–2017) http://pubs.acs.org/doi/full/10.1021/acs.est.6b06343
Fine particles in homes of predominantly low-income families with children and  smokers: Key physical and behavioral determinants to inform indoor-air-quality  interventions (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0177718
Mass spectrometry profiling of oxylipins, endocannabinoids, and N-acylethanolamines in human lung lavage fluids reveals responsiveness of prostaglandin E2 and associated lipid metabolites to biodiesel exhaust exposure (full–2017)  http://link.springer.com/article/10.1007%2Fs00216-017-0243-8
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur  dioxide inhalation via cannabinoid receptors in the brain (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1001074216302340
Biodegradation of Phenol and Benzene by Endophytic Bacterial Strains Isolated from  Refinery Wastewater-Fed Cannabis sativa (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28562230
Occurrence of illicit drugs in water and wastewater, and their removal during wastewater treatment (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0043135417306413
Dose – specific effects of Di-isononyl phthalate on the endocannabinoid system and on  liver of female zebrafish (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28938452
Differential tissue regulation of peroxisome proliferator-activated receptor α (PPARα)  and cannabinoid receptor 1 (CB1) gene transcription pathways by diethylene glycol  dibenzoate (DEGB): preliminary observations in a seabream (Sparus aurata) in vivo  model (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28843100
Occurrence and fate of illicit drugs and pharmaceuticals in wastewater from two  wastewater treatment plants in Costa Rica (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0048969717310471
Grass is not always greener: rodenticide exposure of a threatened species near marijuana growing operations (full–2018)  https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-018-3206-z


POST-OPERATIVE COGNITIVE DYSFUNCTION/POCD/“BRAIN FOG”
Glucocorticoid-endocannabinoid interaction in cardiac surgical patients: relationship to  early cognitive dysfunction and late depression (abst–2012)  http://www.degruyter.com/abstract/j/revneuro.2012.23.issue-5-6/revneuro-2012-0058/revneuro-2012-0058.xml?rskey=jSEJyD&result=10&q=cannabinoid
Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive  impairment in mice through anti-inflammatory activity (full–2017)  https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0913-7


POST-OPERATIVE ILEUS
The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus (full-2013)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067427


POST-OPERATIVE PAIN +
Evidence for a Role of Endocannabinoids, Astrocytes and p38 Phosphorylation in the Resolution of Postoperative Pain (full–2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2878341/?toolmcentrez
Historical essay: An Arabic surgeon, Ibn al Quff’s (1232-1286) account on surgical pain relief (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173333/
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant
for administration by ingestion or other means (Health Canada) (full–2010)  http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Peripheral and Spinal Activation of Cannabinoid Receptors by Joint Mobilization Alleviates Postoperative Pain in Mice (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24120553
Postoperative Analgesia in the Jamaican Cannabis User (abst–2013) http/www.tandfonline.com/doi/full/10.1080/02791072.2013.803644#.U9QCtWN8E24
Intrathecal Injection of JWH015 Attenuates Remifentanil-Induced Postoperative Hyperalgesia by Inhibiting Activation of Spinal Glia in a Rat Model (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24651239
Interaction of a Cannabinoid-2 Agonist With Tramadol on Nociceptive Thresholds and Immune Responses in a Rat Model of Incisional Pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25370921
Endocannabinoids and acute pain after total knee arthroplasty (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25599456
The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation : a case report (full–2015) http://link.springer.com/article/10.1007%2Fs12630-015-0525-6
Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26808012
Plasma endocannabinoid behaviour in total knee and hip arthroplasty (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28078867
Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of  Incision Pain in Rats (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00391/full
The role of the endocannabinoid system in the antihyperalgesic effect of Cedrus atlantica essential oil inhalation in a mouse model of postoperative pain (full–2017)  http://www.sciencedirect.com/science/article/pii/S0378874117320172?via%3Dihub
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders (full–2017) http://www.cpn.or.kr/journal/view.html?volume=15&number=4&spage=301
Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and  Meta-Analysis of Randomized Controlled Trials (link to PDF-2017)  http://www.painphysicianjournal.com/linkout?issn=1533-3159&vol=20&page=E755
A randomized-controlled trial of nabilone for the prevention of acute postoperative  nausea and vomiting in elective surgery. (abst in English & French–2017)  https://link.springer.com/article/10.1007%2Fs12630-017-0814-3
Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2  agonists (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390816305639
A Review of Adjunctive CNS Medications Used for the Treatment of Post-Surgical Pain  (abst–2017) https://link.springer.com/article/10.1007%2Fs40263-017-0440-1
Administrations of thalidomide into the rostral ventromedial medulla produce  antinociceptive effects in a rat model of postoperative pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28758232
Perioperative Patient Beliefs Regarding Potential Effectiveness of Marijuana  (Cannabinoids) for Treatment of Pain: A Prospective Population Survey (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28796754

top


POST POLIO SYNDROME
Palmitoylethanolamide in the Treatment of Chronic Pain Caused by Different  Etiopathogenesis (full–2012)  https://academic.oup.com/painmedicine/article/13/9/1121/1864240
Medical Marijuana Coverage Still Lost in the Legal Weeds (article–2013)  https://www.managedcaremag.com/archives/2013/1/medical-marijuana-coverage-still-lost-legal-weeds


POST-TRAUMATIC STRESS DISORDER/FEAR EXTINCTION/FEAR MEMORY +
The use of Cannnabidiol (CBD) and Meditation to reduce Binge Drinking, Anxiety and to improve Emotional Regulation in Long Term Behavior Therapy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/437/?pagenum=2
PTSD contributes to teen and young adult cannabis use disorders (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784238/?tool=pubmed
Endocannabinoids and psychiatric disorders: the road ahead (article–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000500003&lng=en&nrm=iso&tlng=en
Cannabinoids modulate hippocampal memory and plasticity (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19830813
The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment program (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=309
Cannabinoids and anxiety (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/21309120
The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124830/?tool=pubmed
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242307/
Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation Paradigm (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242302/
Posttraumatic Stress and Marijuana Use Coping Motives: The Mediating Role of Distress Tolerance (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101637/
Posttraumatic stress disorder and Cannabis use in a nationally representative sample (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21480682
Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: Implication for PTSD and drug abuse (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21600961
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats (abst–2011) http://www.sciencedirect.com/science/article/pii/S0028390811003467
Medical cannabis use in post-traumatic stress disorder: a naturalistic observational study (abst–2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=481
Cannabis use among military veterans after residential treatment for posttraumatic stress disorder (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21261407
Possible involvement of the endocannabinoid system in memory modulation effect of  general anesthetics (abst-2011)  http://www.unboundmedicine.com/medline/ebm/record/21555187/abstract/Possible_involvement_of_the_endocannabinoid_system_in_memory_modulation_effect_of_general_anesthetics_
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug (full–2012)  http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000500008&lng=en&nrm=iso&tlng=en
Opposing Roles for Cannabinoid Receptor Type-1 (CB(1)) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242309/
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481531/
Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity (full–2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549323/
Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid Receptors (full–2012) http://www.jneurosci.org/content/32/21/7109.long
On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398715/
top
Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565211/
CADTH Rapid Response Report: Cannabinoids for the treatment of post-traumatic stress disorder (full–2012) http://www.cadth.ca/media/pdf/htis/july-2012/RC0368%20Cannabinoids%20Final.pdf
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242307/
Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22173015
Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo (abst–2012) http://www.sciencedirect.com/science/article/pii/S1074742712000585
Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22534181
Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22736575
Prevalence of Cannabis Use Disorder Diagnoses Among Veterans in 2002, 2008, and 2009 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22564034
The underdiagnosis of cannabis use disorders and other Axis-I disorders among military veterans within VHA (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22808884
Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21906661
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22979992
CB1 receptor activation in the nucleus accumbens core impairs contextual fear learning (abst–2012) http://www.sciencedirect.com/science/article/pii/S0166432812006183
Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21148020
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22979992
Cognitive ability in early adulthood as a predictor of habitual drug use during later military service and civilian life: the Vietnam Experience Study (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22520690
Positron emission tomography offers new perspectives for evidence-based treatment development in PTSD (abst-forum repost–2012) http://forum.grasscity.com/medical-marijuana-usage-applications/1374895-ptsd-study.html
Plasma concentrations of endocannabinoids and related primary Fatty Acid amides in patients with post-traumatic stress disorder (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062741
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752332/
top
Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883309/
The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD) (full–2013)  http://journal.frontiersin.org/Journal/10.3389/fnbeh.2013.00100/full#B12
Recent Progress in Understanding the Pathophysiology of Post-Traumatic Stress Disorder: Implications for Targeted Pharmacological Treatment (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629370/
Translational evidence for the involvement of the endocannabinoid system in stress related psychiatric illnesses (full–2013) http://www.biolmoodanxietydisord.com/content/3/1/19
Cannabinoid facilitation of fear extinction memory recall in humans (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445738/
Involvement of prelimbic medial prefrontal cortex in panic-like elaborated defensive behaviour and innate fear-induced antinociception elicited by GABAA receptor blockade in the dorsomedial and ventromedial hypothalamic nuclei: role of the endocannabinoid CB1 receptor (full–2013) http://ijnp.oxfordjournals.org/content/16/8/1781.long
The endocannabinoid system and emotional processing: A pharmacological fMRI study with ∆9-tetrahydrocannabinol (full–2013) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900195-8/fulltext
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870889/
Amygdala FAAH and anandamide: mediating protection and recovery from stress (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169112/
Using cannabis to help you sleep: Heightened frequency of medical cannabis use among  those with PTSD (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929256/
Toward Rational Pharmacotherapy for Posttraumatic Stress Disorder: Reprise (editorial–2013) http://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2013.13060768
Correspondence (letter to the editor): Cannabis Therapy (letter–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601285/
The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD (1st page–2013) http://onlinelibrary.wiley.com/doi/10.1002/da.22031/abstract
A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers (abst–2013)  http://www.sciencedirect.com/science/article/pii/S002839081200247X
Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0304394012014735
Cannabidiol enhances consolidation of explicit fear extinction in humans (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23307069
Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23433741
top
Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0166432813002532
Cannabinoids and glucocorticoids modulate emotional memory after stress (abst-2013)  http://www.sciencedirect.com/science/article/pii/S0149763413001929
Effects of endocannabinoid and endovanilloid systems on aversive memory extinction (abst–2013) http://www.sciencedirect.com/science/article/pii/S0166432813004865
Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24253425
Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23617872
Effects of the fatty acid amide hydrolase inhibitor URB597 on coping behavior under  challenging conditions in mice (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24037493
PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program (full–2014) http://www.tandfonline.com/doi/full/10.1080/02791072.2013.873843#tabModule
Impaired Fear Memory Specificity Associated with Deficient EndocannabinoidDependent Long-Term Plasticity (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023141/
Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268027/
Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat (full-2014) http://ijnp.oxfordjournals.org/content/18/3/pyu104.long
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area (full–2014) http://www.jneurosci.org/content/34/39/13096.long
Use of a Synthetic Cannabinoid in a Correctional Population for Post-traumatic Stress Disorder-Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications: A Retrospective Evaluation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165471/
Stress regulates endocannabinoid-CB1 receptor signaling (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247817/
Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696509/
Cannabinoid Type 1 Receptor Availability in the Amygdala Mediates Threat Processing in Trauma Survivors (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207337/
Positive posttraumatic stress disorder screens among first-time medical cannabis patients: Prevalence and association with other substance use (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299455/
Interaction between the Cholecystokinin and Endogenous Cannabinoid Systems in Cued Fear Expression and Extinction Retention (full–2014) http://www.nature.com/npp/journal/v40/n3/full/npp2014225a.html
Toward a translational approach to targeting the endocannabinoid system in post-traumatic stress disorder: A critical review of preclinical research (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465924/
Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960373/ Endocannabinoid Signaling within the Basolateral Amygdala Integrates Multiple Stress Hormone Effects on Memory Consolidation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397407/
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059893/
top
When time stands still: an integrative review on the role of chronodisruption in  post-traumatic stress disorder (full–2014)  https://escholarship.org/uc/item/26d306vj
Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing (full–2014) http://www.nature.com/npp/journal/v39/n12/full/npp2014132a.html
Modulation of the extinction of fear learning (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24742526
Marijuana, expectancies, and post-traumatic stress symptoms: a preliminary investigation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25052875
The interaction between serotonergic and cannabinoidergic modulations involved in the fear extinction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25069241
Preliminary, open-label, pilot study of add-on oral δ(9)-tetrahydrocannabinol in chronic post-traumatic stress disorder (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24935052
The learning of fear extinction (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0149763414002681
PTSD Growth and Substance Abuse Among a College Student Community: Coping Strategies after 2009 L’aquila Earthquake (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397827/
Increased contextual fear conditioning in iNOS knockout mice: additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system (full–2015) http://ijnp.oxfordjournals.org/content/18/8/pyv005.long
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study (full–2015) http://www.psyneuen-journal.com/article/S0306-4530%2814%2900413-2/fulltext
Metabolite profiling in posttraumatic stress disorder (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367823/
Targeting the endocannabinoid system to treat anxiety-related disorders (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0058/jbcpp-2015-0058.xml
Fluoxetine Facilitates Fear Extinction through Amygdala Endocannabinoids (full–2015) http://www.nature.com/npp/journal/vaop/ncurrent/full/npp2015318a.html
Narrative review of the safety and efficacy of marijuana for the treatment of commonly
state-approved medical and psychiatric disorders (full–2015)  http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Brain transcriptome profiles in mouse model simulating features of post-traumatic stress disorder (full–2015)  http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-015-0104-3
Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial  Memory Retrieval in Rats (full–2015) http://www.jneurosci.org/content/35/41/13962.long
Cannabidiol as a Potential Treatment for Anxiety Disorders (full–2015)  http://link.springer.com/article/10.1007/s13311-015-0387-1
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling  (full–2015) http://www.cell.com/cell/fulltext/S0092-8674(15)00826-0
Anxiety, Stress, and Fear Response in Mice with Reduced Endocannabinoid Levels (full-2015) http://www.biologicalpsychiatryjournal.com/article/S0006-3223(15)00314-5/fulltext
Neurobiological Interactions Between Stress and the Endocannabinoid System (full–2015) http://www.nature.com/npp/journal/v41/n1/full/npp2015166a.html
The cannabinoid system in the retrosplenial cortex modulates fear memory consolidation, reconsolidation, and extinction (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749733/
Behavioral genetics: of mice, men, and internal bliss (full–2015)  http://www.cell.com/current-biology/fulltext/S0960-9822(15)00414-5
Cannabinoid Receptors May Control Aversive Memories (abstract & news-2015)  http://neurosciencenews.com/habenula-cb1-receptors-memory-2742/
Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26628106
Investigational drugs under development for the treatment of PTSD (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25773140
The endocannabinoid system in guarding against fear, anxiety and stress (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/26585799
Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25799920
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons (abst–2015) http://link.springer.com/article/10.1007%2Fs00213-015-3917-y
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-endoccannabinoid receptor in the ventral mesencephalon (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25841876
The influence of cannabinoids on learning and memory processes of the dorsal striatum (abst–2015) http://www.sciencedirect.com/science/article/pii/S1074742715001148
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Providing a food reward reduces inhibitory avoidance learning in zebrafish (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0376635715300309
Endocannabinoids and Mental Disorders (abst–2015)  http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_8
Modulation of cannabinoid signaling by amygdala α2-adrenergic system in fear conditioning (abst–2015) http://www.sciencedirect.com/science/article/pii/S0166432815303259
Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815302161
Marijuana dependence moderates the effect of posttraumatic stress disorder on trauma cue reactivity in substance dependent patients (abst–2015) http://www.sciencedirect.com/science/article/pii/S0376871615018293
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26449928
top
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory (full–2016) http://www.hindawi.com/journals/np/2016/9817089/
2-arachidonoylglycerol signaling impairs short-term fear extinction (full–2016) http://www.nature.com/tp/journal/v6/n3/full/tp201626a.html
Modulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726806/
Cannabis use among Navy personnel in Sri Lanka: a cross sectional study (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794863/
Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment (full–2016) http://journals.lww.com/tnpj/Fulltext/2016/01000/Cannabis_for_posttraumatic_stress_disorder__A.6.aspx
Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder (full–2016)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155759#pone.0155759.ref024
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology (full–2016) https://elifesciences.org/content/5/e14137
Genetic variation in the endocannabinoid system and response to Cognitive Behavior Therapy for child anxiety disorders (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/ajmg.b.32467/full
PTSD: from neurobiology to pharmacological treatments (full–2016) http://www.ejpt.net/index.php/ejpt/article/view/31858
Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00454/full
Modulation of Long-Term Potentiation of Cortico-Amygdala Synaptic Responses and Auditory Fear Memory by Dietary Polyunsaturated Fatty Acid (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993868/
Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00493/full
The association of specific traumatic experiences with cannabis initiation and transition
to problem use: Differences between African-American and European-American women  (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833569/
Associations of Posttraumatic Stress Disorder Symptoms With Marijuana and Synthetic  Cannabis Use Among Young Adult U.S. Veterans: A Pilot Investigation (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869907/
Impaired Ethanol- Induced Sensitization and Decreased Cannabinoid Receptor-1 in a  Model of Posttraumatic Stress Disorder (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871361/
Marijuana Could Help Treat Drug Addiction and Mental Health Problems (news & abst–2016) http://neurosciencenews.com/addiction-mental-health-marijuana-5536/
Modulation of cannabinoid signaling by hippocampal 5-HT4 serotonergic system in fear  conditioning (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27296273
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26767992
Sex differences in hippocampal response to endocannabinoids after exposure to severe stress (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26928784
Endocannabinoid concentrations in hair are associated with PTSD symptom severity (abst–2016) http://www.psyneuen-journal.com/article/S0306-4530%2816%2930040-3/abstract
CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301393
Cannabidiol Modulates Fear Memory Formation through Interactions with Serotonergic Transmission in the Mesolimbic System (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27296152
The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings (abst–2016) http://www.sciencedirect.com/science/article/pii/S104366181630706X
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27475408
Understanding resilience: New approaches for preventing and treating PTSD (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27417856
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27551883
Dorsal hippocampus cannabinoid type 1 receptors modulate the expression of contextual fear conditioning in rats: Involvement of local glutamatergic/nitrergic and GABAergic neurotransmissions (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27591981
Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27698427
FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27716956
Targeting the Endocannabinoid System in Psychiatric Illness (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27811555
Regulation of fear extinction by long-term depression: the roles of endocannabinoids and brain derived neurotrophic factor (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27867101
Considering Future Pharmacotherapy for PTSD (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016309004
Cannabinoid modulation of zebrafish fear learning and its functional analysis investigated by c-Fos expression (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716302854
Modulation of cannabinoid signaling by hippocampal 5-HT4 serotonergic system in fear  conditioning (abst–2016)  http://journals.sagepub.com/doi/full/10.1177/0269881116652584
Precondition of right frontal region with anodal tDCS can restore the fear memory  impairment induced by ACPA in male mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318674/
Endocannabinoid signalling modulates susceptibility to traumatic stress exposure (full–2017) http://www.nature.com/articles/ncomms14782
Impact of Cannabis Use on Treatment Outcomes among Adults Receiving Cognitive Behavioral Treatment for PTSD and Substance Use Disorders (full–2017)  http://www.mdpi.com/2077-0383/6/2/14/htm
Medical Marijuana for Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness and Guidelines (full–2017) https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0095901/
Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions  through conditional genetic rescue in forebrain GABAergic neurons (full–2017)
https://link.springer.com/article/10.1007%2Fs00429-017-1411-5
Social Isolation in Early versus Late Adolescent Mice Is Associated with Persistent  Behavioral Deficits That Can Be Improved by Neurosteroid-Based Treatment (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581875/
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders (full–2017) http://www.cpn.or.kr/journal/view.html?volume=15&number=4&spage=301
PTSD and Cannabis-Related Coping Among Recent Veterans in New York City (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475281/
Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to  amygdalar cannabinoid-1 (CB1) receptors (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670208/
The Endocannabinoid System Differentially Regulates Escape Behavior in Mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655002/
Cannabinoid Modulation of the Stressed Hippocampus (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742214/
Benefits and Harms of Cannabis in Chronic Pain or Post-traumatic Stress Disorder: A  Systematic Review (full–2017)  https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0098113/
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and  cued-arousal among veterans who screen positive for PTSD (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0306460317300072
The involvement of cannabinoids and mTOR in the reconsolidation of an emotional  memory in the hippocampal-amygdala-insular circuit (abst–2017)  http://www.europeanneuropsychopharmacology.com/article/S0924-977X(17)30025-1/fulltext
Extinction of avoidance behavior by safety learning depends on endocannabinoid  signaling in the hippocampus (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28222356
The endocannabinoid system modulating levels of consciousness, emotions and likely  dream contents (abst–2017) http://www.eurekaselect.com/150392/article
Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A  literature review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28245077
Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28268256
Cannabinoids as therapeutic for PTSD (abst–2017)  http://www.sciencedirect.com/science/article/pii/S2352250X16302342
Selective post-training time window for memory consolidation interference of  cannabidiol into the prefrontal cortex: reduced dopaminergic modulation and immediate gene expression in limbic circuits (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28344069
Cannabis, Cannabinoids, and Sleep: a Review of the Literature (abst–2017)  http://link.springer.com/article/10.1007%2Fs11920-017-0775-9
Role of the amygdala GABA-A receptors in ACPA-induced deficits during conditioned fear learning (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28389208
Prefrontal endocannabinoids, stress controllability and resilience: A hypothesis (abst–2017) http://www.sciencedirect.com/science/article/pii/S0278584616302470
Anxious behavior induces elevated hippocampal Cb2 Receptor gene expression (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28392296
The endocannabinoid system as a target for novel anxiolytic drugs (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0149763416304699
Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit  composition: A biomarker axis in stress-induced cognitive and emotional impairment  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28456011
N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of  contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal  hippocampus (abst–2017)  http://journals.sagepub.com/doi/full/10.1177/0269881117691567
Daily-level associations between PTSD and cannabis use among young sexual minority  women (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28618391
Role of beta-catenin and endocannabinoids in the nucleus accumbens in extinction in rats exposed to shock and reminders (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28624572
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28653665
Cannabinoids prevent the differential long-term effects of exposure to severe stress on  hippocampal- and amygdala-dependent memory and plasticity (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28667676
Effects of cannabinoid drugs on aversive or rewarding drug-associated memory  extinction and reconsolidation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28729064
Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28745306
Cannabidiol disrupts the consolidation of specific and generalized fear memories via  dorsal hippocampus CB1 and CB2 receptors (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817303556?via%3Dihub
DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and  Related Conditions-III: Gender-specific profiles (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28755613
Demographic and clinical characteristics of treatment seeking women with full and  subthreshold PTSD and concurrent cannabis and cocaine use disorders (abst–2017) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(17)30009-0/fulltext
Cannabinoids as therapeutic for PTSD (abst–2017)  http://www.sciencedirect.com/science/article/pii/S2352250X16302342
The effects of cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala and hippocampus on the consolidation of a traumatic event (abst–2017) http://www.sciencedirect.com/science/article/pii/S1074742717301284?via%3Dihub
Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse  hippocampus (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28888955
Changes in Gene Expression in the Locus Coeruleus-Amygdala Circuitry in Inhibitory Avoidance PTSD Model (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28889197
Enhanced anandamide signaling reduces flight behavior elicited by an approaching robobeetle (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817304276?via%3Dihub
Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories:  focus on cannabinoids and ketamine (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4793-4
Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction  Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29265107
Psychobiological Responses to Aerobic Exercise in Individuals With Posttraumatic Stress
Disorder (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29388710


POTENCY*+
Δ9-Tetrahydrocannabinol content in cannabis samples seized in Novi Sad during 2008  (full–2010) http://www.shd.org.rs/JSCS/Vol75/No7/02_4595_4015.pdf
Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008 (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/20487147/abstract/Potency_trends_of_%CE%949_THC_and_other_cannabinoids_in_confiscated_cannabis_preparations_from_1993_to_2008
The results of an experimental indoor hydroponic Cannabis growing study, using the  ‘Screen of Green’ (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20462712
How Accurate is Potency Testing? (full–2011) http://www.canorml.org/RingTestOShaughnessys_Aut11.pdf
The Effect of Electrical Lighting Power and Irradiance on Indoor-Grown Cannabis Potency and Yield (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22211717
A real-time PCR assay for the relative quantification of the tetrahydrocannabinolic acid  (THCA) synthase gene in herbal Cannabis samples (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/22093702
Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335956/
It can’t hurt to ask; a patient-centered quality of service assessment of health canada’s  medical cannabis policy and program (full–2012)  https://harmreductionjournal.biomedcentral.com/articles/10.1186/1477-7517-9-2
AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as
evidenced by drug discrimination in rats and hypothermia testing in mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291515/
Inhalation exposure to smoke from synthetic “marijuana” produces potent  cannabimimetic effects in mice (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501554/
Is today’s marijuana more potent simply because it’s fresher? (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/dta.1430/full
A survey of the potency of Japanese illicit cannabis in fiscal year 2010 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22554871
Evolution of the Content of THC and Other Major Cannabinoids in Drug-Type Cannabis Cuttings and Seedlings During Growth of Plants (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22390363
First systematic evaluation of the potency of Cannabis sativa plants grown in Albania (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22608266
Structure and Function of Δ1-Tetrahydrocannabinolic Acid (THCA) Synthase, the
Enzyme Controlling the Psychoactivity of Cannabis sativa (abst-2012)  http://www.sciencedirect.com/science/article/pii/S0022283612005220
Analgesic effects of cannabinoids on central pain syndrome (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22359935
Cannabis Strain Explorer (web page-2012) http://www.leafly.com/explore
Cannabis, a complex plant: different compounds and different effects on individuals  (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736954/
Marijuana’s dose-dependent effects in daily marijuana smokers (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547548/
Toxicological Findings of Synthetic Cannabinoids in Recreational Users (full–2013) https://academic.oup.com/jat/article-lookup/doi/10.1093/jat/bkt068
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0070052
Effect and occurrence of synthetic cannabinoids (abst in English–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23736196 (full in Norwegian ) http://tidsskriftet.no/2012/10/oversiktsartikkel/syntetiske-cannabinoider-effekt-og-forekomst
Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23020923
THE EFFECT OF ABA ON PIGMENTS AND TETRAHYDROCANNABINOL IN CANNABIS SATIVA AT FLOWERING STAGE (abst–2013) http://en.journals.sid.ir/ViewPaper.aspx?ID=351874
Variability of cannabis potency in the Venice area (Italy): A survey over the period 2010-2012 (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/dta.1515/full
Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/add.12508/full
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical Grade Cannabis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747979
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
top
Just say ‘know’: how do cannabinoid concentrations influence users’ estimates of cannabis potency and the amount they roll in joints? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24894801
Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydro-cannabinol in recreational users: a randomized, crossover clinical trial (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24879495
Selective monoacylglycerol lipase inhibitors: Antinociceptive vs cannabimimetic effects in mice (full–2015) http://jpet.aspetjournals.org/content/early/2015/03/11/jpet.114.222315.long
No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456813/
Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497846/
Marijuana gears up for production high in US labs (article–2015) http://www.nature.com/news/marijuana-gears-up-for-production-high-in-us-labs-1.17129
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products (letter–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338239
Potency 101 (printable card set–2015) (good info!) http://greenstyleconsulting.com/potency-101/
Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25788107
Sequence heterogeneity of cannabidiolic- and tetrahydrocannabinolic acid-synthase in Cannabis sativa L. and its relationship with chemical phenotype (abst–2015) http://www.sciencedirect.com/science/article/pii/S0031942215001181
Effect of induced polyploidy on some biochemical parameters in Cannabis sativa L (abst–2015) https://link.springer.com/article/10.1007%2Fs12010-014-1435-8
Evaluation of elemental profiling methods, including laser-induced breakdown spectroscopy (LIBS), for the differentiation of Cannabis plant material grown in different nutrient solutions (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25898182
(1)H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0039914015001228
Potency trends of Δ9 -THC, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-2015 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26234170
Determination of the relative percentage distribution of THCA and Δ9-THC in herbal cannabis seized in Austria – Impact of different storage temperatures on stability (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26247127
top

Tetrahydrocannabinol pharmacokinetics; new synthetic cannabinoids; road safety and cannabis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26427296
Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13390/full
Evaluating the Effects of Gamma-Irradiation for Decontamination of Medicinal Cannabis (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00108/full
Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to marijuana? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881394/
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00279/full
Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines (full–2016) http://www.ajtr.org/files/ajtr0030292.pdf
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032490/
Analysis of a commerical marijuana e-cigarette formulation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867395/
A content analysis of tweets about high-potency marijuana (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983477/
Edible Cannabis Products: It is Time for FDA Oversight (full–2016)  http://www.accp1.org/documents/2016BenjaminEdibleCannabisProducts.pdf
Compromised External Validity: Federally Produced Cannabis Does Not Reflect Legal  Markets (link to PDF–2016) http://biorxiv.org/content/early/2016/10/26/083444
Use of marijuana for medical purposes (link to PDF–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27660881
Changes in cannabis potency over the last two decades (1995-2014) – Analysis of current data in the United States (abst–2016) http://www.sciencedirect.com/science/article/pii/S0006322316000457
Cannabinoids for treatment of glaucoma (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26840343
Cannabis-induced psychosis associated with high potency “wax dabs” (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876313
“Those edibles hit hard”: Exploration of Twitter data on cannabis edibles in the U.S. (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716%2816%2930056-4/abstract
Pharmacological characterization of emerging synthetic cannabinoids in HEK293T cells and hippocampal neurons (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27260125
Enhanced discriminative stimulus effects of Δ9-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30133-8/abstract
Limitations to the Dutch cannabis toleration policy: Assumptions underlying the reclassification of cannabis above 15% THC (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27471078
Stability of Tetrahydrocannabinol and Cannabidiol in Prepared Quality Control Medible Brownies (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27798074
A study of cannabis potency in France over a 25 years period (1992-2016) (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28122324
Disruption of hippocampal synaptic transmission and long-term potentiation by  psychoactive synthetic cannabinoid ‘Spice’ compounds: comparison with Δ9 –
tetrahydrocannabinol (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26732435
Focus on cannabinoids and synthetic cannabinoids (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27861784
Cannabinoid concentrations in Canada’s regulated medical cannabis industry (full–2017) http://onlinelibrary.wiley.com/doi/10.1111/add.13738/full
Recreational Cannabis — Minimizing the Health Risks from Legalization (full–2017) http://www.nejm.org/doi/full/10.1056/NEJMp1614783
Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition  and Relation to Pharmacodynamic Outcomes (brownies) (full–2017) https://academic.oup.com/jat/article-lookup/doi/10.1093/jat/bkx012
Determination of delta-9-tetrahydrocannabinol content of cannabis seizures in Egypt  (full–2017) http://www.sciencedirect.com/science/article/pii/S1995764516304266
Cannabis and Multiple Sclerosis—The Way Forward (full–2017)  http://journal.frontiersin.org/article/10.3389/fneur.2017.00299/full
Measuring cannabis consumption: Psychometric properties of the Daily Sessions,  Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU) (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446174/
Consumer use and understanding of labelling information on edible marijuana products  sold for recreational use in the states of Colorado and Washington (full–2017)  http://www.ijdp.org/article/S0955-3959(17)30008-7/fulltext
Terpene synthases from Cannabis sativa (full–2017)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0173911
Comparison of the discriminative stimulus and response rate effects of Δ9-
tetrahydrocannabinol and synthetic cannabinoids in female and male rats (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30005-4/fulltext
Can we make cannabis safer? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28259650
Marijuana on the Mind? The Impact of Marijuana on Cognition, Brain Structure, and  Brain Function, and Related Public Policy Implications (abst–2017)  http://journals.sagepub.com/doi/full/10.1177/2372732216684851
Perceived harms and benefits of tobacco, marijuana, and electronic vaporizers among  young adults in Colorado: Implications for health education and research (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28449191
Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis (abst–2017) http://www.psy-journal.com/article/S0165-1781(17)30055-0/fulltext
Variation in cannabis potency and prices in a newly-legal market: Evidence from 30  million cannabis sales in Washington State (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28556310
A Metabolomic Approach Applied to a Liquid Chromatography Coupled to High Resolution Tandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the
Comprehensive Evaluation of the Chemical Composition of Cannabis Medicinal Extracts (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28915313
Evaluation of Cannabinoid and Terpenoid Content: Cannabis Flower Compared to  Supercritical CO2 Concentrate (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28926863
Cannabinoids concentration variability in cannabis olive oil galenic preparations (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29057480
Legal cannabis laws, home cultivation, and use of edible cannabis products: A growing  relationship? (abst–2017)  http://www.ijdp.org/article/S0955-3959(17)30292-X/fulltext
Practical considerations in medical cannabis administration and dosing (abst–2017)  http://www.ejinme.com/article/S0953-6205(18)30004-9/fulltext
Cannabis Use, Lung Cancer, and Related Issues (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29374567
Changes in cannabis potency and first-time admissions to drug treatment: a 16-year  study in the Netherlands (full–2018)  https://www.cambridge.org/core/journals/psychological-medicine/article/changes-in-cannabis-potency-and-firsttime-admissions-todrug-treatment-a-16year-study-in-the-netherlands/998695133558A106254C6291CD12FC06/core-reader


PRADER WILLI SYNDROME
Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038245/
Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123200/

Hedonic eating in Prader-Willi syndrome is associated with blunted PYY secretion (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475322/


PREGNANCY/PRENATAL EXPOSURE*+
The Maternal Lifestyle Study: Sleep Problems in Children with Prenatal Substance Exposure (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917192/?tool=pubmed
N-Acylethanolamine Levels and Expression of Their Metabolizing Enzymes during Pregnancy (full–2010) http/endo.endojournals.org/content/151/8/3965.full
Effects of abnormal cannabidiol on oxytocin-induced myometrial contractility (full–2010) http://www.reproduction-online.org/content/139/4/783.long
Cannabinoids and Reproduction: A Lasting and Intriguing History (link to PDF–2010) http/www.mdpi.com/1424-8247/3/10/3275
From Fertilisation to Implantation in Mammalian Pregnancy-Modulation of Early Human Reproduction by the Endocannabinoid System (link to PDF–2010) http/www.mdpi.com/1424-8247/3/9/2910
Tocolytic Effect of Δ9-Tetrahydrocannabinol in Mice Model of Lipopolysaccharide—
Induced Preterm Delivery: Role of Nitric Oxide (abst-2010)  http://journals.sagepub.com/doi/abs/10.1177/1933719109358456
A prospective study on intrauterine cannabis exposure and fetal blood flow (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/20451334
Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20369362
A common variation in the cannabinoid 1 receptor (CNR1) gene is associated with preeclampsia in the Central European population (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/21129839
Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/20171023
Endocannabinoids and pregnancy (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/20302856
Scientific Opinion on the safety of hemp (Cannabis genus) for use as animal feed (full–2011) (deceptive title) http/www.hanf-info.ch/info/en/IMG/pdf/EIHA-11-05-31_EIHA-Statement_on_THC_in_feed.pdf
top
Sex difference in cell proliferation in developing rat amygdala mediated by endo-cannabinoids has implications for social behavior (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2996668/?toolubmed
Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3188826/?toolubmed
The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility (full–2011) http://humupd.oxfordjournals.org/content/17/3/347.long
Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137183/?tool=pubmed
Modulation of the novel cannabinoid receptor – GPR55 – during rat fetoplacental development (full–2011) http://www.placentajournal.org/article/S0143-4004%2811%2900110-X/fulltext
Medical Marijuana: Can Pot Help Pregnant Women With Vomiting and Nausea? (article–2011) http/patients4medicalmarijuana.wordpress.com/2011/01/13/pregnancy-and-medical-marijuana-can-pothelp-pregnant-women-with-vomiting-and-nausea/
Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and vomiting of pregnancy (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21170540
Endocannabinoid signaling in female reproduction (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3382454/
Uncovering a role for endocannabinoid signaling in autophagy in preimplantation mouse embryos (full–2012) http/molehr.oxfordjournals.org/content/19/2/93.full
Ectopic pregnancy is associated with high anandamide levels and aberrant expression of FAAH and CB1 in fallopian tubes (full–2012) http/press.endocrine.org/doi/full/10.1210/jc.2012-1780
Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrier (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525865/
Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3229.long
Type-1 Cannabinoid Receptor Signaling in Neuronal Development (full–2012)  http://www.karger.com/Article/FullText/339075
Acetaminophen, pesticide, and diethylhexyl phthalate metabolites, anandamide, and fatty acids in deciduous molars: potential biomarkers of perinatal exposure (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22805989
Cannabinoid modulation of mother-infant interaction: is it just about milk? (abst–2012) http/www.degruyter.com/abstract/j/revneuro.2012.23.issue-5-6/revneuro-2012-0074/revneuro-2012-0074.xml?rskey=wRYgJd&result=1&q=cannabinoid
Elevated Anandamide and Related N-Acylethanolamine Levels Occur in the Peripheral Blood of Women With Ectopic Pregnancy and Are Mirrored by Changes in Peripheral Fatty Acid Amide Hydrolase Activity (full–2013) http/press.endocrine.org/doi/full/10.1210/jc.2012-3390
top
Detection of In Utero Marijuana Exposure by GC–MS, Ultra-Sensitive ELISA and LC–TOF–MS Using Umbilical Cord Tissue (full–2013) http/jat.oxfordjournals.org/content/early/2013/07/09/jat.bkt052.full
Embryonic diapause in humans: time to consider? (full–2013) http/www.rbej.com/content/11/1/92
The Effect of Mifepristone (RU486) on the Endocannabinoid System in Human Plasma and First Trimester Trophoblast of Women undergoing Termination of Pregnancy (full–2013) http://press.endocrine.org/doi/full/10.1210/jc.2013-2922
Synthetic cannabinoids and potential reproductive consequences (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823745/
Differential expression of endocannabinoid system in normal and preeclamptic placentas: effects on nitric oxide synthesis (full-2013)  http://www.placentajournal.org/article/S0143-404%2812%2900393-1/fulltext
Of mice and (wo)men: factors influencing successful implantation including endocannabinoids (full–2013) http://humupd.oxfordjournals.org/content/20/3/415.long
Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity (full–2013) http://www.placentajournal.org/article/S0143-4004%2813%2900692-9/fulltext
Long-term consequences of perinatal fatty acid amino hydrolase inhibition (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954482/
The role of endocannabinoids in pregnancy (download–2013) http://www.reproduction-online.org/content/early/2013/06/06/REP-12-0508.long
Detection of the endocannabinoid metabolome in human plasma and breast milk (abst–2013)  http://www.fasebj.org/content/27/1_Supplement/45.8.short
Endocannabinoid receptor (CB1R) deficiency affects maternal care and alters the dam’s hippocampal oxytocin receptor and BDNF expression (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23895426
Diagnostic Value of Concentration Profiles of Glucocorticosteroids and Endocannabinoids in Hair (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23942543
Plasma Anandamide and Related N-acylethanolamide Levels are not Elevated in Pregnancies Complicated by Hyperemesis Gravidarum (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24117326
Regulation of GPR55 in rat white adipose tissue and serum LPI by nutritional status,  gestation, gender and pituitary factors (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0303720713005261
Increased placental expression of cannabinoid receptor 1 in preeclampsia: an observational study (full–2014) http://www.ncbi.nlm.nih.gov/pubmed/25444073
The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: Involvement of both mitochondrial and death receptor pathways (full–2014) http://www.placentajournal.org/article/S0143-4004%2814%2900823-6/fulltext
Endocannabinoids as biomarkers of human reproduction (full–2014)
http://humupd.oxfordjournals.org/content/20/4/501.long
Endocannabinoid Regulation in Human Endometrium Across the Menstrual Cycle (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527420/
Fatty Acid Binding Protein-4 is expressed in the mouse placental labyrinth, yet is dispensable for placental triglyceride accumulation and fetal growth (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170794/
top
Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis (full–2014) http://hyper.ahajournals.org/content/64/3/619.long
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Activity of anandamide (AEA) metabolic enzymes in rat placental bed (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0890623814001993
Contribution of in utero drug exposure when interpreting hair results in young children (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25450508
Prenatal exposure to recreational drugs affects global motion perception in preschool
children (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652269/
Local uterine Ang-(1-7) infusion augments the expression of cannabinoid receptors and differentially alters endocannabinoid metabolizing enzymes in the decidualized uterus of pseudopregnant rats (full–2015) http://www.rbej.com/content/13/1/5
Increased Plasma Levels of FABP4 and PTEN Is Associated with More Severe Insulin Resistance in Women with Gestational Diabetes Mellitus (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329941/
Lipid mediator profile in vernix caseosa reflects skin barrier development (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629127/
Gestation Related Gene Expression of the Endocannabinoid Pathway in Rat Placenta (full–2015) http://www.hindawi.com/journals/mi/2015/850471/
A role for GPR55 in human placental venous endothelial cells (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487816/
Use of paracetamol during pregnancy and child neurological development (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/dmcn.12745/full
Dynamics of expression and localization of the cannabinoid system in granulosa cells during oocyte nuclear maturation (full–2015) http://www.fertstert.org/article/S0015-0282(15)00440-9/fulltext
Role of the endocannabinoid system in the mechanisms involved in the LPS-induced  preterm labor (full–2015) http://www.reproduction-online.org/content/150/6/463.long
Preferential epithelial expression of type-1 cannabinoid receptor (CB1R) in the  developing canine embryo (full–2015) http://www.springerplus.com/content/4/1/804
Decreased circulating anandamide levels in preeclampsia (download–2015)  https://core.ac.uk/download/pdf/78472108.pdf
Progesterone and anandamide in pregnancy loss (link to download–2015)  http://www.placentajournal.org/article/S0143-4004%2815%2900515-9/fulltext
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Participation of the endocannabinoid system (ECS) in the weight-gain and sensitization to LPS exposure in a maternal obesity model (article–2015) http://www.placentajournal.org/article/S0143-4004%2815%2900526-3/fulltext
CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/nyas.12642/full
top
[268-POS]: Placental expression of the endocannabinoid system in preeclampsia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25787618
[16-OR]: Vasoactive lipid mediators control uterine vascular reactivity at early pregnancy in the transgenic hAGNxhREN rat (abst–2015) http://www.sciencedirect.com/science/article/pii/S2210778914001214
Endocannabinoid Levels in Newborns in Relation to the Mode of Delivery (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25915139
Lipopolysaccharide-induced murine embryonic resorption involves changes in endo-cannabinoid profiling and alters progesterone secretion and inflammatory response by a CB1-mediated fashion (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0303720715002348
Anandamide restricts uterine stromal differentiation and is critical for complete decidualization (abst–2015) http://www.sciencedirect.com/science/article/pii/S0303720715002257
Maternal marijuana use and neonatal morbidity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26026918
The endocannabinoid anandamide affects the synthesis of human syncytiotrophoblast related proteins (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26202891
Association between marijuana use and adverse obstetrical and neonatal outcomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26401751
Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes  (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25895138
Maternal age and trajectories of cannabis use (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2901662-2/abstract
Exposure to a Highly Caloric Palatable Diet During Pregestational and Gestational Periods Affects Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Adiposity and Anxiety-Like Behaviors in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2015.00339/full
top
Differential Regulation of Eicosanoid and Endocannabinoid Production by Inflammatory Mediators in Human Choriodecidua (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0148306

Maternal marijuana use has independent effects on risk for spontaneous preterm birth but not other common late pregnancy complications (full–2016) http://www.sciencedirect.com/science/article/pii/S0890623816300715
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016182a.html
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00208/full
Dietary conjugated linoleic acid supplementation alters the expression of genes involved  in the endocannabinoid system in the bovine endometrium and increases plasma  progesterone concentrations (full–2016) http://www.theriojournal.com/article/S0093-691X(16)30134-0/fulltext
Sustained Endocannabinoid Signaling Compromises Decidual Function and Promotes  Inflammation-induced Preterm Birth (download–2016)  http://www.jbc.org/content/early/2016/02/21/jbc.M115.707836.long
Anandamide interferes with human endometrial stromal-derived cell differentiation: An effect dependent on inhibition of cyclooxygenase-2 expression and prostaglandin E2 release (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26945481
The endocannabinoid system: an emergent player in human placentation (abst–2016) http://www.sciencedirect.com/science/article/pii/S0890623816300260
Alcohol, Methamphetamine, and Marijuana Exposure Have Distinct Effects on the Human Placenta (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27038593
Conceptus development and transcriptome at preimplantation stages in lactating dairy cows of distinct genetic groups and estrous cyclic statuses (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27016828
Expression analysis of cannabinoid receptors 1 and 2 in B cells during pregnancy and their role on cytokine production (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27163857
Marijuana Use and Its Effects in Pregnancy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27263998
Heparin exerts anti-apoptotic effects on uterine explants by targeting the endocannabinoid system (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364950
A role for the endocannabinoid system in premature luteal regression and progesterone withdrawal in lipopolysaccharide-induced early pregnancy loss model (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27470501
Endocannabinoids participate in placental apoptosis induced by hypoxia inducible factor- 1 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27488203
The endocannabinoid anandamide impairs in vitro decidualization of human cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568210
Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal / early postnatal history (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27634313
Bisphenol A induces hypothalamic down-regulation of CB1 and anorexigenic effects in male mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27641926
Peripheral Blood Mononuclear Cells Infiltration Downregulates Decidual FAAH Activity in an LPS-Induced Embryo Resorption Model (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27731508
A role for the endocannabinoid system in premature luteal regression and progesterone withdrawal in lipopolysaccharide-induced early pregnancy loss model (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27470501
Evaluating a switch from meconium to umbilical cord tissue for newborn drug testing: A retrospective study at an academic medical center (abst–2016) http://www.sciencedirect.com/science/article/pii/S0009912016306087
Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27959272
Adolescent Female Cannabinoid Exposure Diminishes the Reward-Facilitating Effects of  Δ9-Tetrahydrocannabinol and d-Amphetamine in the Adult Male Offspring (full–2017) http://journal.frontiersin.org/article/10.3389/fphar.2017.00225/full
What effects—if any—does marijuana use during pregnancy have on the fetus or child?  (full–2017) http://www.mdedge.com/jfponline/article/141775/pediatrics/what-effects-if-any-does-marijuana-use-during-pregnancy-have
Overactive type 2 cannabinoid receptor induces meiosis in fetal gonads and impairs  ovarian reserve (full–2017)  http://www.nature.com/cddis/journal/v8/n10/full/cddis2017496a.html?foxtrotcallback=true
A moderate diet restriction during pregnancy alters the levels of endocannabinoids and  endocannabinoid-related lipids in the hypothalamus, hippocampus and olfactory bulb of
rat offspring in a sex-specific manner (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0174307
Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation  and Pain (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628559/
The Roles of Anandamide, Fatty Acid Amide Hydrolase, and Leukemia Inhibitory Factor  on the Endometrium during the Implantation Window (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650704/
Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction (full–2017)  https://www.karger.com/Article/FullText/477603
Mothering under the influence: how perinatal drugs of abuse alter the mother-infant  interaction (full–2017)  https://www.degruyter.com/view/j/revneuro.ahead-of-print/revneuro-2017-0052/revneuro-2017-0052.xml
Do Clinicians Ask Pregnant Women about Exposures to Tobacco and Cannabis Smoking,  Second-Hand-Smoke and E-Cigarettes? An Australian National Cross-Sectional Survey  (full–2017) http://www.mdpi.com/1660-4601/14/12/1585/htm
Trends in Self-reported and Biochemically Tested Marijuana Use Among Pregnant  Females in California From 2009-2016 (1st page–2017)  https://jamanetwork.com/journals/jama/article-abstract/2667052?redirect=true
Developmental Patterns of Adolescent Marijuana and Alcohol Use and Their Joint  Association with Sexual Risk Behavior and Outcomes in Young Adulthood (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28083726
Anandamide oxidative metabolism-induced endoplasmic reticulum stress and apoptosis  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28220271
Prevalence of illicit drug use at the end of pregnancy: a cross-sectional study at the time  of birth (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28176511
Assessment of tobacco, alcohol and cannabinoid metabolites in 645 meconium samples  of newborns compared to maternal self-reports (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28237885
Pregnant Women’s Current and Intended Cannabis Use in Relation to Their Views  Toward Legalization and Knowledge of Potential Harm (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28252456
Sex-dependent effects of neonatal maternal deprivation on endocannabinoid levels in the adipose tissue: influence of diet (abst–2017)  http://link.springer.com/article/10.1007%2Fs13105-017-0558-0
CB1 cannabinoid receptor drives oocyte maturation and embryo development via  PI3K/Akt and MAPK pathways (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28428264
Cannabis use by women during pregnancy does not influence infant DNA methylation of  the dopamine receptor DRD4 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28448718
Evidence for CB2 receptor involvement in LPS-induced reduction of cAMP intracellular  levels in uterine explants from pregnant mice: pathophysiological implications (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28460003
Spatial distribution of cannabinoid receptor 1 and fatty acid amide hydrolase in the cat  ovary and oviduct (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28478955
The synthetic cannabinoid WIN-55,212-55,212 induced-apoptosis in cytotrophoblasts  cells by a mechanism dependent on CB1 receptor (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28495606
High times for cannabis: Epigenetic imprint and its legacy on brain and behavior (abst–2017) http://www.sciencedirect.com/science/article/pii/S0149763417300659
Maternal alcohol exposure during mid-pregnancy dilates fetal cerebral arteries via  endocannabinoid receptors (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28554529
Marijuana and tobacco co-use among a nationally representative sample of US pregnant  and non-pregnant women: 2005-2014 National Survey on Drug Use and Health findings  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28599211
Pharmacologic Implications of Marijuana Use During Pregnancy (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28599743
PLACENTA AS ALTERNATIVE SPECIMEN TO DETECT IN UTERO CANNABIS EXPOSURE: A SYSTEMATIC REVIEW OF THE LITERATURE (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0890623817300199
A case of cannabinoid hyperemesis syndrome with heliobacter pylori and pre-eclampsia  during pregnancy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28723278
The endocannabinoid system expression in the female reproductive tract is modulated by estrogen (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0960076017301887
Cannabis Use during Pregnancy: Pharmacokinetics and Effects on Child Development  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28847562
Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0009912016307081
Perinatal maternal high-fat diet induces early obesity and sex-specific alterations of the  endocannabinoid system in white and brown adipose tissue of weanling rat offspring  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29110748
EFFECT OF MATERNAL HIGH-FAT DIET ON KEY COMPONENTS OF THE PLACENTAL AND HEPATIC ENDOCANNABINOID SYSTEM (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29138223
Maternal Cannabinoid Use Alters Cannabinoid (CB1) and Endothelin (ETB) Receptor  Expression in the Brains of Dams but Not Their Offspring (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29131068
Interpretation of cannabis findings in the hair of very young children: mission impossible (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29189142
Metformin attenuates susceptibility to inflammation-induced preterm birth in mice with  higher endocannabinoid levels (abst–2017)  https://academic.oup.com/biolreprod/advance-article-abstract/doi/10.1093/biolre/iox164/4693831?redirectedFrom=fulltext
Marijuana use during pregnancy: A comparison of trends and correlates among married  and unmarried pregnant women (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30531-8/fulltext
RhoA/MLC signaling pathway is involved in Δ⁹-tetrahydrocannabinol-impaired placental  angiogenesis (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0378427417315412?via%3Dihub
Marijuana-Perinatal and Legal Issues With Use During Pregnancy (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29373417


PRIMARY LATERAL SCLEROSIS
Self-medication with cannabidiol oil in a patient with primary lateral sclerosis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28397674


PRIONS +
Alteration of the Endocannabinoid System In Mouse Brain During Prion Disease (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21195746


PROSTATIC HYPERPLASIA/BPH/ENLARGED PROSTATE GLAND/PROSTATITIS +
Transient receptor potential A1 and cannabinoid receptor activity in human normal and hyperplastic prostate: relation to nerves and interstitial cells (full–2010)  http://www.europeanurology.com/article/S0302-2838(09)00861-6/fulltext
Misdiagnosed chronic pelvic pain: pudendal neuralgia responding to a novel use of
palmitoylethanolamide (full–2010)  http://painmedicine.oxfordjournals.org/content/11/5/781.long
Distribution and Possible Function of Cannabinoid Receptor Subtype 1 in the Human Prostate*—An Inhibitory Role for Growth in the Human Prostate Cancer (full–2013) http://file.scirp.org/Html/12-5000121_31406.htm
Future direction in pharmacotherapy for non-neurogenic male lower urinary tract symptoms (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23711541
Stimulation of cannabinoid receptors by using Rubus coreanus extracts to control osteoporosis in aged male rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25136745
A survey of cannabis (marijuana) use and self-reported benefit in men with chronic prostatitis/chronic pelvic pain syndrome (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277530/
Fatty Acid Amide Hydrolase Inhibitor Treatment in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome, an Adaptive Double-Blind Randomized Controlled Trial (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28254462


PRURITIS/ITCH
The Management of Chronic Pruritus in the Elderly (full–2010) http/www.skintherapyletter.com/2010/15.8/2.html
CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3606913/
Is there a legitimate role for the therapeutic use of cannabinoids for symptom management in chronic kidney disease? (full–2011)  http://www.jpsmjournal.com/article/S0885-3924%2810%2900979-6/fulltext
Endocannabinoid signaling and epidermal differentiation (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21628127
Differences in peripheral endocannabinoid modulation of scratching behavior in facial vs spinally-innervated skin (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394407/
Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agent (abst–2012) http://www.sciencedirect.com/science/article/pii/S0960894X12002429 
top
Discovery of S-777469: an orally available CB2 agonist as an antipruritic agent (abst–2012)  http://www.sciencedirect.com/science/article/pii/S0960894X12002739
On the g-protein-coupled receptor heteromers and their allosteric receptor-receptor interactions in the central nervous system: focus on their role in pain modulation (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3730365/
Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23142959
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22697514
Understanding itch: An update on mediators and mechanisms of pruritus (full–2014)  http://www.ijdvl.com/article.asp?issn=0378-6323;year=2014;volume=80;issue=2;spage=106;epage=114;aulast=Hassan
Evaluation of sex differences in cannabinoid dependence (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971653/
Blockade of cannabinoid CB1 and CB2 receptors does not prevent the antipruritic effect of systemic paracetamol (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24399199
The effect of propofol on intrathecal morphine-induced pruritus and its mechanism (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24445631
Cannabinoid 1 receptors in keratinocytes attenuate FITC-induced mouse atopic-like dermatitis (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24750433
Attenuation of serotonin-induced itch responses by inhibition of endocannabinoid degradative enzymes, fatty acid amide hydrolase and monoacylglycerol lipase (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24915981
S-777469, a Novel Cannabinoid Type 2 Receptor Agonist, Suppresses Itch-Associated Scratching Behavior in Rodents through Inhibition of Itch Signal Transmission (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25721168
Uremic Pruritus Is Not Associated with Endocannabinoid Receptor 1 Gene Polymorphisms (full–2016) http://www.hindawi.com/journals/bmri/2016/3567527/

The Gut-Itch Connection (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/exd.12994/full
Cannabis and Dr Piffard-A Century Ahead of the Curve (article–2016) http://archderm.jamanetwork.com/article.aspx?articleid=2547236
Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27720681
Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL
inhibitors produce antipruritic effect in mice (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27126057
Descending serotonergic and noradrenergic systems do not regulate the antipruritic effects of cannabinoids (abst–2016) https://www.cambridge.org/core/journals/acta-neuropsychiatrica/article/descending-serotonergic-andnoradrenergic-systems-do-not-regulate-the-antipruritic-effects-ofcannabinoids/5BE6C9C7BA28268807D522354F70199A
The role of cannabinoids in dermatology (full–2017) http://www.jaad.org/article/S0190-9622(17)30308-0/fulltext
The Endocannabinoid System and Its Role in Eczematous Dermatoses (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28098721
Echinacea purpurea-derived alkylamides exhibit potent anti-inflammatory effects and  alleviate clinical symptoms of atopic eczema (abst–2017)  http://www.jdsjournal.com/article/S0923-1811(16)31025-8/fulltext


PSEUDOMONAS AERUGINOSA
Discovery of Desketoraloxifene Analogues as Inhibitors of Mammalian, Pseudomonas aeruginosa, and NAPE Phospholipase D Enzymes (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336625/


PSORIASIS +
Endocannabinoid signaling and epidermal differentiation (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21628127
Cannabinoid Treatment for Psoriasis Symptoms (article–2012)  https://www.medicalmarijuana.com/medical-marijuana-treatments-cannabis-uses/cannabinoid-treatment-for-psoriasis-symptoms/
A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ (full–2013) https/peerj.com/articles/40/
Effect of narrowband ultraviolet B treatment on endocannabinoid plasma levels in psoriasis patients (abst–2014) http/onlinelibrary.wiley.com/doi/10.1111/bjd.12916/abstract
Harnessing neuroendocrine controls of keratin expression: A new therapeutic strategy for skin diseases? (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24823963
top
Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model (full–2016) http://anndermatol.org/DOIx.php?id=10.5021/ad.2016.28.1.22

Cannabis for refractory psoriasis-high hopes for a novel treatment and a literature review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27164964
Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27694494
Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of  Vascular Dementia (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460147/
The oxylipin and endocannabidome responses in acute phase Plasmodium falciparum
malaria in children (full–2017)  https://malariajournal.biomedcentral.com/articles/10.1186/s12936-017-2001-y
The role of cannabinoids in dermatology (full–2017) http://www.jaad.org/article/S0190-9622(17)30308-0/fulltext
Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28110689


PYODERMA GANGRENOSUM
Topical Medical Cannabis (TMC): A new treatment for wound pain-Three cases of  Pyoderma Gangrenosum (abst–2017)  http://www.jpsmjournal.com/article/S0885-3924(17)30351-2/fulltext
top


Advertisements